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ABSTRACT
Neisseria meningitidis is the major cause of invasive meningococcal disease (IMD) (Peterson et
al, 2018). Approximately 10-15 percent of IMD cases result in debility including neurological
impairment, amputation, and death (Peterson et al, 2018). Outbreaks of IMD are sporadic and
unpredictable. The incidence of IMD varies geographically, but serogroup B has become more
prevalent in recent years. Meningitis-B (Men-B) has been the cause of several university
outbreaks on different US college campuses since 2013.The purpose of this project was to
implement an intervention at a midwestern university student health center to help students
understand the risk of the disease and the importance of receiving the Meningococcal
vaccination. A determination was made that the health center needed an intervention for
education of these students to assist in vaccination uptake. Best practice recommendation from
the literature included implementation of a provider reminder to screen and offer the Men-B
vaccination, educational efforts, and the initiation of a poster campaign around campus
regarding the disease and importance of vaccination. The project implementation included
screening eligible participants over 13 weeks at a midwestern university health center. A brightly
colored reminder was placed on each of the staff laptops to screen and offer the vaccination to
those who met criteria. Posters were placed around campus in areas that students frequently
attend. Educational brochures were given to eligible students at the time of their visit and a
template in the electronic health record was created to flag patients that have received the
vaccine and when they will be due for their second dose. A compliance tracking form was
created for the clinic staff (N=5) to fill out daily in order to evaluate project intervention
compliance. Data were collected from student charts to determine eligibility as well as vaccine
administration post intervention. A chi-square analysis was performed (X2 (1)=26.112, p<0.05),
indicating statistical significance.
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CHAPTER 1
INTRODUCTION
Background
Neisseria meningitidis, a gram-negative bacterium, is the major cause of invasive
meningococcal disease (IMD) (Peterson et al, 2018). The bacterium is often carried by about
10% of the human population in their pharynx (Peterson, et al, 2018). Approximately 10-15% of
IMD cases result in debility including neurological impairment, amputation, and death (Peterson
et al, 2018). The disease is transmitted through droplets, such as those from oral or nasal
passages through mechanisms such as coughing, sneezing and sharing beverages and food.
Those most at risk include young children, adolescents, immunocompromised individuals, and
students who attend universities or are living in college dormitories (Peterson et al, 2018; CrumCianflone & Sullivan, 2016).
Outbreaks of IMD are sporadic and unpredictable. Since 2013, there have been three
university-based outbreaks in the United States (US) (Baker, 2016). In 2017, there were
approximately 350 cases of meningococcal disease reported in the US. The highest incidence
of the disease occurs in children less than one year old and those between the ages of 16 and
23 years old (CDC, 2019). There are twelve serogroups (subtypes) of meningococcal disease,
six (A,B,C,W, X, & Y) are capable of causing epidemics (WHO, 2019). The highest incidence is
reported in sub-Saharan Africa, in which epidemics caused by Group A have occurred every 1012 years. Groups B and C are responsible for most cases in North and South America,
Australia, New Zealand, and Europe (WHO, 2019).
Vaccination is the best form of prevention for this disease. Since 1999, a conjugate
vaccine has been available against Group C and a quadrivalent vaccine against Group A, C, Y,
and W has been available since 2005 (WHO, 2019). Vaccination against Group B has just
recently been made available in 2014. It is recommended that children aged 11-12 years old
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receive the MenACYW vaccination with a booster dose at 16 years of age. Those that are
between the ages of 16-23 years old are recommended to receive the Men-B vaccination (CDC,
2019).
Data from the Literature Supporting Need for the Project
The incidence of IMD varies geographically, but serogroup B has become more
prevalent in recent years. Men-B has been the cause of several university outbreaks on different
US college campuses since 2013 (Baker, 2016). During February 2019, Rutgers University in
New Brunswick, NJ had two undergraduate students test positive for Men-B (CDC, 2019;
Rutgers University, 2019). The students tested positive approximately two weeks apart and
subsequently, this was deemed an outbreak by the CDC. The students were treated promptly
and survived without any complications (Rutgers University, 2019). In addition, during the same
time period, another Men-B outbreak involving two students at Columbia University in New York
occurred (CDC, 2019; Columbia University, 2019). These students were also hospitalized,
treated, and recovered. Other Men-B outbreaks occurred in September 2018 and April 2019 at
San Diego University (CDC, 2019; Health & Human Services Agency, 2019). Approximately 3040% of all IMD cases in the US are caused by the serogroup B (Baker, 2016). The CDC (2019)
notes that approximately 10-15 in 100 people that acquire the meningococcal infection will die.
They also note that about 1 in 5 survivors will have long-term disabilities from the disease such
as deafness, loss of limbs, nervous system debilities, and brain damage. In 2017 the CDC
issued its most recent report which stated that there were 350 reported cases of Men-B
occurring over multiple age groups, the highest incidence occurring between the ages of 16 and
23 years old (CDC, 2017). Within this study, it was estimated that 65% of those infected were
college students. According to the report 43.9% of those students had received information
regarding the disease but did not receive the vaccination. During that year, there were a total of
16 deaths in the US related to IMD, three of which occurred in the 16-23-year age group. IMD

MENINGOCOCCAL PROTOCOL

3

remains a major global health threat that can cause major debilities and even death. The
disease is largely preventable by vaccination (Crum-Cianflone & Sullivan, 2016).
In addition to the poor health outcomes associated with IMD, there are many costs
associated with caring for those who contract the illness. Balada-Llasat (2018) completed a
study to compare costs of the many tests associated with a meningitis infection. They found that
the average cost to care for one patient with bacterial meningitis is $26,501. These costs
include hospitalization, diagnostic testing, and antimicrobial therapy (Balada-Lllasat, 2018).
While receiving treatment, patients are typically in droplet isolation until after 24 hours of initial
treatment with an effective antibiotic. Antibiotic therapy for the disease typically lasts from seven
to fourteen days, depending on the causative bacteria (El Bashir, Laundy, & Booy, 2019).
Although the rates of IMD are low, the severity of illness is high. Neurologic and physical
debility are associated with the disease and IMD has a 10-15% mortality rate (Peterson et al,
2018). To prevent infection and debility, as well as lower healthcare costs associated with the
disease, vaccination rates need to increase, especially in high risk populations. College-aged
students are at increased risk of contracting the illness; therefore, an intervention is necessary
to increase vaccination rates in this population.
Data from the Clinical Agency Supporting Need for the Project
The project was implemented in a midwestern university student health center (SHC).
The SHC serves a diverse group of students varying in age, race, and ethnicity. During the
2018-2019 school year, the student body was comprised of 71.8% white ethnicity, 9.4%
Hispanic, 5.5% Black/African American, and 2.1% were of Asian descent. Additionally, 4.1%
were international students, 3.5% multi-racial, 0.1% were American Indian/Alaskan Native, and
3.5% were not reported (University X, 2019). The SHC offers many services to full or part time
students including preventative services such as immunizations as well as sick visits (University
X, 2019). According to the university, any graduate student enrolled in nine or more credit hours
and any undergraduate enrolled in twelve or more credit hours must utilize the university health
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insurance plan. However, students can obtain other insurance outside of the SHC, but must
waive out of the student insurance plan and provide proof of insurance (University X, 2019).
When students use the SHC, immunizations, medications, and physician visits are generally
covered in full. The co-pays and deductibles are waived, making healthcare affordable to
students (University X, 2019). According to the university insurance plan (2019), the Men-B
vaccine would be a covered preventative service, if administered by a preferred provider,
including the SHC. Cost, therefore, would not be a barrier to students receiving the vaccine.
(University X, 2019).
According to the program director, from May 2018 to May 2019 there were 2,703 total
health center visits, making this a frequent place to meet student’s healthcare needs (K.
Eshenaur, personal communication, 2019). The university did not receive the Men-B vaccination
until May 2019. There were only 56 Men-B vaccinations given during May 2019-August 2019
(University X Health Center, 2019). Since there are no current mechanisms for screening for
the vaccination, there is no way to know the true vaccination rate. There have been no reported
outbreaks of Men-B at this specific university since it was founded in 1859 (Meningitis B Action
Project, 2019; K. Eshenaur, personal communication, 2019). Despite no reported outbreaks, the
severity of this disease is such that increased vaccination rates are warranted.
Due to the disease severity and increased risk to college students, a decision was made
by the Provost of the university to mandate vaccination for all incoming freshman, both living on
campus and commuters (K. Eshenaur, personal communication, 2019). While incoming
students are mandated to have the vaccination before attendance at the university beginning
the 2019-2020 school year, already enrolled students have no such mandate. The rest of the
student body remains at risk of disease. Therefore, further vaccination in this population and in
this setting is required.
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Purpose of the Evidence-Based Practice Project
It is estimated that 30-40% of all IMD cases in the US are caused by the serogroup B
(Baker, 2016). Approximately 10-15 in 100 cases of the meningococcal infection result in fatality
They also note that about 1 in 5 survivors will have long-term disabilities from the disease such
as deafness, loss of limbs, nervous system debilities, and brain damage. College students are
at an increased risk of contracting Men-B due to the transmission by respiratory droplets and
living in close quarters such as dormitories. There is compelling evidence and support from the
CDC and WHO, as well as other agencies to focus efforts on increasing vaccination rates of
Men-B due to the severity of the disease. Additionally, there was much support for an
intervention focused on increasing Men-B vaccination rates by the site director, identifying an
essential need for an intervention to increase Men-B vaccination uptake. The purpose of this
EBP project was to influence the college student population at risk, age 23 and under, to receive
the Men-B vaccination. By implementing an intervention to promote the immunization, a positive
outcome for prevention of disease can be achieved.
PICOT Question
According to Schmidt and Brown (2019) the PICOT format was designed to formulate
EBP questions to find the most relevant evidence. The format includes identifying (a) Patient
population, (b) Intervention of interest, (c) Comparison of interest, (d) Outcome of interest, and
(e) Time utilized. Specifically, this project addressed the following PICOT question: In college
students (P), does the implementation of an intervention to educate students on the meningitis
disease and importance of vaccination, a vaccination screening and provider reminder, and a
campus-wide vaccination campaign (I) as compared to no intervention (C), increase Men-B
vaccination rates (O), over thirteen weeks (T) ?.
Significance of the EBP Project
This EBP project aimed to implement an intervention that will help increase the
vaccination rates of a potentially fatal disease. Prior to project implementation, immunization

MENINGOCOCCAL PROTOCOL

6

rates for Men-B at the SHC were low and there was no intervention in place to increase rates.
Despite the new mandate for all incoming students, the risk of contracting Men-B remained high
among the remainder of the student body. According to the CDC (2017), there were
approximately 350 cases of Men-B reported in 2017; 65% of those were college students and
43.9% of those students had received the information regarding the disease but did not receive
the vaccination. Further intervention was needed to emphasize the risk and prevent this deadly
disease. If the intervention is successful, the SHC can utilize it for future immunization practices.
This project can prevent mortality and morbidity among college students and their contacts.
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CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
Overview of EBP Model
For this evidence-based practice (EBP) project, multiple models were reviewed to guide
its direction including the Iowa Model of EBP, Advancing Research and Clinical Practice through
Close Collaboration (ARCC) model, the Promoting Action on Research Implementation in
Health Services (PARIHS) model, the Academic Center for Evidence-Based Practice (ACE)
model, and the Stetler Model. The Stetler model was chosen because it utilizes step by step
guidelines to direct EBP. The core of the model is critical thinking and use of research findings
(Melnyk & Fineout-Overholt, 2015), both which are essential to this project. Critical thinking was
necessary to differentiate evidence findings and applying the evidence into a practice setting
was the foundation of this project. Utilizing critical thinking was a large part of this EBP project in
order to synthesize the evidence to support this project. For a novice leader, the Stetler model
was ideal as its use of step by step guidelines was easily understood and applied to this project.
Since this EBP project was complex, step by step direction was just what was needed to
simplify and direct the activities of the project. The model is user-friendly and designed in a
manner that is easy to understand as well as to apply to this EBP project.
The Stetler model was developed to “formulate a series of critical-thinking and decisionmaking steps designed to facilitate safe and effective use of research findings” (Stetler, 2001, p.
273). According to Melnyk & Fineout-Overholt (2015), the Stetler model has been known to be a
“practitioner-oriented model” (p.279) due to its focus on critical thinking as well as its ability for
the practitioner to utilize its findings. This model was designed to guide critical thinking as well
as decision-making among practitioners as well as aid in effective use of the research findings
(Stetler, 2001). The model is divided into five different phases: (1) preparation, (2) validation, (3)
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comparative evaluation/decision making, (4) translation/application, and (5) evaluation (Melnyk
& Fineout-Overholt, 2015).
Phase I: Preparation. During this phase, a significant need is defined and a systematic
search for pertinent evidence is initiated (Melnyk & Fineout-Overholt, 2015).The preparation
phase consists of recognizing high priority issues, identifying key stakeholders, forming a project
team, and delineating applicable desired outcomes (Stetler, 2001). This is achieved by selecting
research sources, assessing internal evidence, and pursuing systematic reviews.
Phase II: Validation. The validation phase consists of critiquing the literature for
applicability and reliability. A table of evidence is created, and evidence is then graded and
rated. Statistical and clinical significance is identified, and non-credible sources are eliminated
(Stetler, 2001). The decision to continue with the research process is made if there is enough
credible evidence. The process ceases if there is insufficient evidence to support practice
change.
Phase III: Comparative Evaluation/Decision Making. Cumulative findings are
synthesized in phase three. Similarities and differences of the findings are organized among the
pieces of evidence. Feasibility of the findings is determined including urgency/risk of current
issues/needs, resources, and readiness of the clinical site (Melnyk & Fineout-Overholt, 2015;
Stetler, 2001). Evidence is then organized, and decisions are made regarding what findings to
use or not to use. If a decision is made to utilize the research findings, it can mean a
recommendation for or against a specific practice. If a decision is made not to employ the
findings, then further research may be conducted, or it can be delayed until additional research
is done by others (Melnyk & Fineout-Overholt, 2015).
Phase IV: Translation/Application. The translation/application phase consists of
translating the research findings and applying them to practice. The research is disseminated,
and practice changes are made based on current recommendations (Stetler, 2001). A plan is
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made, key stakeholders such as staff are educated, and the plan is implemented based on the
evidence that was synthesized and met inclusion criteria.
Phase V: Evaluation. The final phase consists of assessing the plan that was
implemented. The outcomes are also examined for consistency with the evidence identified in
the literature. (Melnyk & Fineout-Overholt, 2015). Stetler (2001) states that formative and
summative data must be synthesized during this phase. Formative data includes information
related to the actual implementation of the research findings and whether they were used as
planned. Summative data evaluates if the goal of the project was met (Stetler, 2001).
Application of EBP Model to DNP Project
Phase I: Preparation. In the first phase of this model, the need for an intervention to
increase Men-B vaccinations at a student health center (SHC) was identified by the advanced
practice nurse (APN) who also served as the clinical director. Key stakeholders were identified
according to the Stetler model including the clinic director, staff nurse, medical assistant, and
physician at the university health center. According to the APN, Men-B immunization rates were
low. The conversation deemed that a project was needed in order to aid in increasing
immunization rates among college students (K. Eshenaur, personal communication, 2019). It
was also noted that there were no interventions in place prior to implementation to help increase
Men-B immunization rates on this campus. Starting fall 2019, the university planned to increase
Men-B vaccination rates over a four- year period, by mandating all incoming students to have
had the vaccination prior to attending the university (K. Eshenaur, personal communication,
2019). However, this plan still left many students unprotected and the need for an intervention to
increase vaccination rates amongst the remainder of the student body was identified.
Supporting evidence on the importance of this vaccination in college students was noted.
According to the Centers for Disease Control (CDC) (2017), college campuses are at risk for
outbreaks of meningococcal disease due to communal living in close spaces such as
dormitories. Although infection rates are low, the risk remains high for neurological debilities,
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amputation, and even death if the disease is contracted (Peterson, et al, 2018). After the need
for an intervention was recognized, an intensive literature search was performed using key
search terms and developed inclusion and exclusion criteria.
Phase II: Validation: Evidence was reviewed and critiqued using the Johns Hopkins
Nursing Evidence Based Practice (JHNEBP) appraisal tool. This appraisal tool provided a
detailed, yet understandable guide to identify a level and assign a grade to the evidence found.
Inclusion and exclusion criteria of (1) not freshman status, (2) under the age of 23, and (3) have
not received Men-B vaccine were developed. Evidence-based practice for increasing
vaccination rates was identified to support a practice change. The appropriate evidence was
then summarized and graded, and a rating level was applied.
Phase III: Comparative Evaluation/Decision making. The appropriate evidence was
compared, and similarities were identified. After the evidence from 14 articles was appraised, it
was concluded that a laminated reminder should be placed on the staff’s workstations to review
vaccination history as well as offer the Men-B vaccination, if applicable. It was noted that
provider reminders placed in the EHR were also successful; however, it was deemed most
feasible by the clinic director, as well as the project leader, to place the laminated reminder on
the workstations, rather than place the reminder in each EHR. Educational modalities were also
noted to increase vaccination rates and poster campaigns were said to be successful.
Educational brochures regarding the Men-B disease, as well as the Men-B vaccination were
given to patients while waiting in the examination room and a poster campaign was also placed
in multiple locations around campus that are most frequented by students. The process of
creating marketing strategies, a provider reminder, and education for students in need of the
vaccination was developed with key stakeholders of the SHC. The intervention was deemed
feasible by the project manager as well as the clinical director in this specific setting. The
decision was made to carry out the evidence-based recommendations.
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Phase IV: Translation/Application. The Stetler model was successfully utilized to
guide the implementation of this EBP project. This was achieved through the inclusion of key
stakeholders in the development of the implementation plan, which was designed based upon
the appraisal and synthesis of evidence. Based on the evidence appraised and best practice
recommendations, a multicomponent process was created that was deemed feasible by the
clinical director of the SHC. Multiple factors were considered during this phase to assess
feasibility of implementation of this project. These included the willingness of the providers and
staff to acknowledge the reminder, provide the patient with the education, and offer the
vaccination. To overcome any barriers, strategies were developed to help the project run
without incident. These strategies included staff education with a step-by-step process of the
project and their duties within the project. Questions were answered along the way and
continued education was given until the interventions ran smoothly within the day to day
workflow. Every Wednesday during implementation, the staff had a huddle for one hour to go
over processes within the SHC. The project leader attended these huddles to assess project
flow and to address any issues the staff may be having.
Phase V: Evaluation. Once data was collected after implementation of the evidencebased practice recommendations, the data was then synthesized to determine the impact of the
intervention on meningitis B vaccinations at the SHC based on the Stetler model guidelines.
During this period, the Men-B vaccination rates from May 2019 were compared to vaccination
rates post intervention, to assess if the primary objective was met, and if the provider prompt,
education, and poster campaign did in fact increase vaccination rates. During this phase, a
compliance form was created for the SHC staff. The staff were to indicate on the form if the
student met eligibility criteria, if education was given, as well as if the vaccine was offered and
then given or declined; then the staff were to sign their name.
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Strengths and Limitations of EBP Model for DNP Project
Strengths of the Stetler model include that it is focused on critical thinking, which is an
essential component of this project. The model is also known for being practitioner oriented and
is noted to be useful and user-friendly to APNs (Stetler, 2010). The model incorporates critical
thinking during the EBP processes by emphasizing a focus on the heart of the problem as well
as the outcomes desired. The Stetler model is also useful because it assesses the strength of
the evidence and its ability to be applied in specific settings (Stetler, 2010). The model also
focuses on implementation and evaluation related to the desired outcomes (Stetler, 2010). For
example, the first portion of this project was identifying the problem of low Men-B vaccination
rates at the SHC, searching for relevant evidence on ways to increase vaccination uptake ,
synthesizing and appraising that evidence, and then applying it to the SHC setting. Desired
outcomes of increased vaccination rates were also defined. The evidence found was then
implemented and applied at the SHC and the project was then evaluated to see if desired
outcomes were met.
While there are many strengths of this EBP model, there are noted weaknesses.
According to Stetler (2010), the model has not been tested thoroughly, so it is not differentiated
from other EBP models. The model is noted to have many different versions, so finding the most
updated version of the model has proven to be challenging. Stetler (2010) also notes that the
model is designed for an individual who is experienced with its steps and uses it on a routine
basis, so use for this project could prove to be difficult for an inexperienced individual.

Literature Search
Sources Examined for Relevant Evidence
An exhaustive search for evidence was completed using the following search engines:
Cumulative Index for Nursing and Allied Health (CINAHL), Medline with Full Text, Nursing &
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Allied Health Database, Joanna Briggs Institute EBP Database (JBI), PubMed, and the
Cochrane Library.
Keywords that were utilized during the search in CINAHL, Medline with Full Text,
Nursing & Allied Health Database, and PubMed included “clinician reminder*” OR “portal
message*” OR “reminder* system*”, OR “patient remind*” OR “provider prompt*” OR
“healthcare provid* prompt*” AND vaccine* OR immuniz* OR immunis*. The search terms
vaccine* OR immuniz* AND remind* were used in JBI as well as the Cochrane Library. Using
these search terms, CINAHL yielded 28 results, Medline with Full Text, 66 results, Nursing &
Allied Health Database, 271 results, JBI, 18 results, PubMed, 403 results, and the Cochrane
Library, 10 results. Due to the overwhelming results of PubMed, an additional limiter, review
articles, was applied and yielded 53 results. Duplicate articles were then eliminated from each
search. As an additional strategy, three articles were citation chased and reviewed, but were
deemed to be not applicable to this project after review.
Inclusion criteria included (a) scholarly, peer reviewed journals, (b) English language,
and (c) published between the years 2009-2019. In addition, exclusion criteria were developed
to ensure applicability to this EBP project. These criteria included (a) dates outside of the 20092019 timeline, and (b) interventions that focused on patient reminders only, as well as (c)
articles that did not focus on immunizations. Articles were not required to include the
meningococcal vaccine, as interventions to increase vaccine uptake can be generalizable. Once
inclusion and exclusion criteria were applied, abstracts were reviewed for adequate
recommendations and evidence related to this project. Two additional articles were reviewed
through citation chasing to ensure further evidence was not missed. Once data saturation was
achieved, 19 articles were then intensely reviewed for adequacy and 14 were chosen for
inclusion into this project and appraised critically (See Table 2.1)
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Table 2.1
Evidence Summary

Citation (APA)

Purpose

Arditi, C., RegeWalther, M., Durieux,
P., & Burnand, B.
(2017). Computergenerated reminders
delivered on paper to
healthcare
professionals: Effects
on professional
practice and
healthcare outcomes
(review). Cochrane
Database of
Systematic
Reviews, 7(7), 1-107.
doi:10.1002/14651858
.CD001175.pub4

Evaluating the
effects of
automatic
computergenerated
reminders that
are printed and
delivered on
paper to the
healthcare
provider
related to
patient health
conditions as
well as the
providers
quality of care.

Design
Systematic
Review

Sample
35 studies
30
Randomized
control trials
5 nonrandomized
studies

Measurement
Reminders overall
improved quality of
care by 6.8%
Reminders alone
improved the
quality of care by
11%
Quality of care
included the
provider utilizing
current guidelines
and research
findings to give the
patient up to date
recommendations.
The reminder
would provide the
healthcare
professional with
the most up to date
recommendations
regarding
screenings due for
the patient and
current
recommendations
out be given.

Results/Findings
The review indicated that
computer generated reminders
that are delivered on paper
improve the quality of care
overall.
Reminders can be implemented
in a variety of settings, so they
can be generalized.

Level/
Quality
Level
I/Grade
B
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Daly, K. L., Halon, P.
A., Aronowitz, T., &
Ross, G. (2016). A
university health
initiative to increase
human papillomavirus
vaccination rates. The
Journal for Nurse
Practitioners, 12(6),
e281-e286.
doi:10.1016/j.nurpra.2
016.02.013

To assist in
increasing the
acknowledgem
ent of patient’s
vaccination
history by the
provider to
prevent
opportunities
for
vaccinations
being missed.

D’Agostino, S. (2016).
Utilization of EHR
provider prompts to
maximize adult
pertussis
immunization rates.
Journal of Doctoral
Nursing Practice, 9(2),
183-188.
doi:10.1891/23809418.9.2.183

To assess if
pertussis
vaccination
rates increase
with the use of
EHR clinical
reminders.

15
Quality
improvement
program

950 eligible
visits

At check-in,
patients were
asked “How many
doses of the HPV
vaccine have you
received in your
lifetime”. Patients
were prompted to
respond. The
response then
automatically
generated a
graph in the EHR
that prompted the
provider to
acknowledge the
vaccine history
before moving on
Non-randomized
352 records
interventionselected from
control study
April 1, 2011May 1, 2011.
Computerized
clinical reminder
Study occurred
that was visible to from
the provider when September 29,
the patient’s chart 2011-October
was opened. The 31, 2011-60
reminder required intervention
acknowledgemen and 60 control
t by the provider
EHR’s were
before allowing to selected

EHR reports were
monitored for
provider
acknowledgement
of vaccine history
as well as provider
recommendations
for vaccination

158 HPV vaccines were
administered to 120 patients

Level
V/Grad
eB

This represented at 13-fold
increase in the number of
vaccines administered as the
previous semester only
administered 12
Provider acknowledgement of
vaccine history was noted to be
at 92%

Primary outcome
measure was the
administration of
the pertussis
vaccine.
Retrospective chart
review for baseline
(preintervention)
and control groups.
The EHR was used
to record both the
intervention and

8.3% of eligible patients received
the pertussis vaccination in the
intervention group (p <.01),
compared to 5%, who did not
receive the clinical reminder (
p=0.08)
Results indicate that the use of a
clinical reminder in the EHR may
increase pertussis immunization
rates

Level
III/
Grade
C
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move on to the
rest of the visit.

Francis, D. B., Cates,
J. R., Wagner, K. P.
G., Zola, T., Fitter, J.
E., & Coyne-Beasley,
T. (2017).
Communication
technologies to
improve HPV
vaccination initiation
and completion: A
systematic review.
Patient Education and
Counseling, 100(7),
1280-1286.
doi:10.1016/j.pec.201
7.02.004

To assess
multiple
studies that
test the effects
of
communication
technology on
HPV
vaccinations.

Grivas, P. D., Devata,
S., Khoriaty, R.,
Boonstra, P. S., Ruch,
J., McDonnell, K., . . .
Worden, F. P. (2017).
Low-cost intervention
to increase influenza
vaccination rate at a

To determine if
a best practice
alert or a
laminated
reminder
placed in the
patient’s chart
would help

Systematic
Review

K=12 studies
reviewed,
cumulative
sample size of
N=38,945,
median N per
study=1596
Median age
was 16.61
years for
participants

Experimental
study

All adult and
pediatric
patients
without
influenza
vaccination for
the 2011-2012

control group’s
vaccination rates
over one month
All interventions
were conducted in
healthcare settings
with one being on a
college campus.
Half of the
interventions (k=5)
targeted parents,
k=5 targeted
patients, and k=3
targeted providers
Multiple
interventions
including EHR
reminder prompts
(k=3), text
messaging (k=3),
automated phone
calls (k=3),
interactive
computer videos
(k=2), and email
(k=2) were noted.
Three providerdirected
interventions were
employed (a) a
“best practice alert”
was in the chart
and was visible to
the provider upon

Two studies targeted providers
only and used EHR promptsstudies showed mixed resultsone study showed a significantly
higher vaccination rate in the
intervention group, and one study
showed no difference

Level
I/Grade
B

Computer technology prompts for
providers and parents appear to
increase vaccination rates.

37.6% increase in adult
vaccination rates for the 20112012 season and a 56.1%
increase in 2012-2013 season.
The provider surveys determined
that 70% of the providers
considered the laminated

Level
V/
Grade
B
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comprehensive cancer
center. Journal of
Cancer Education,
32(4), 871-877.
doi:10.1007/s13187016-1017-2
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increase
influenza
vaccination
rates.

and 2012-2013
seasons

entering the
patients EHR, (b) a
laminated
reminder, placed in
the patients
physical chart and
clinical room
workstations that
prompt the provider
to ask about the
vaccination, and (c)
a bright pink sticker
attached to the
patient’s
medication
reconciliation list
asking if the patient
received the
vaccination, if not, it
asked if they
wanted to speak to
the provider
regarding the
vaccination

reminder useful, while 36%
considered the “best practice
alert” useful.
88% overall support the
continuation of the overall
intervention.

Surveys were given
to the provider to
determine uptake
and satisfaction of
the intervention
Humiston, S. G.,
Bennett, N. M., Long,
C., Eberly, S., Arvelo,
L., Stankaitis, J., &
Szilagyi, P. G. (2011).

To assess if
different
interventions
such as patient
tracking and

Randomized
Control Trial
(RCT)

3,752 eligible
participants
2,004 were
placed in the
control group

Chi-square tests
were used to
compare the
control and
intervention group

64% of participants in the
intervention group were
vaccinated versus 22% in the
control group

Level I/
Grade
B
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Increasing inner-city
adult influenza
vaccination rates: A
randomized controlled
trial. Public Health
Reports (1974-),
126(2_suppl), 39-47.
doi:10.1177/00333549
111260S206

outreach and
provider
reminders
influence
influenza
immunization
rates in
seniors.

18
and 1,748
were placed in
the
intervention
group
Multiple
interventions
were
implemented
including
patient
tracking,
provider
reminders,
patient
reminders and
recall, and
outreach to
patients.
Provider
reminders
included a
brightly colored
flag included in
the patient’s
chart that read
“REMEMBER!
This patient
needs the
influenza
vaccine”
The form
included a field

Combined interventions of patient
tracking, recall, outreach, as well
as provider reminders increased
influenza vaccination rates
among seniors, compared with
standard-of-care control subjects.
The results indicate that it may be
generalizable to similar settings.
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Jaca, A., Mathebula,
L., Iweze, A., Pienaar,
E., & Wiysonge, C. S.
(2018). A systematic
review of strategies for
reducing missed
opportunities for
vaccination. Vaccine,
36(21), 2921-2927.
doi:10.1016/j.vaccine.
2018.04.028

To evaluate if
missed
vaccination
rates were
affected by
different
interventions
including
provider
prompts,
vaccination
reminder
cards, patient
education, and
patient
reminders.

Systematic
Review of
multiple
Randomized
Control Trials

Shojania, K.,
Jennings, A., Mayhew,
A., Ramsay, C.,
Eccles, M., &

To assess the
effect of point
of care, on
screen

Systematic
Review

to indicated if
the vaccine
was
administered,
or if not, a
reason would
need to be
provided.
Six included
studies
comprised of
three RCT’s,
two cluster
randomized
trials, and one
cohort study.
The studies
included at
total of 92,525
children,
adolescents,
and adults.

28 studies that
included 32
comparisons

Several
interventions were
noted among the
studies including
-placing a missed
opportunity for
vaccination (MOV)
sticker on the
charts of children
needing
immunization
-provider prompts
-postcards
-telephone calls
-home visits
-brightly colored
vaccination
reminder card to
the front of the
medical chart
-providers were
given chocolate
bars labeled
“Immunize on time”
Computer
reminders achieved
a median
improvement in

Review suggests that the use of
provider education and prompts,
patient education, patient
tracking, and outreach reduce
MOV and increase vaccination
coverage

Level
I/Grade
C

“Computer reminders delivered at
the point of care have achieved
variable improvements in target
behaviors and processes of care”

Level
I/Grade
B
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Grimshaw, J. (2009).
The effects of onscreen, point of care
computer reminders
on processes and
outcomes of care.
(review). Cochrane
Database of
Systematic Reviews,
(3), CD001096CD001096.
doi:10.1002/14651858
.CD001096.pub2

computer
reminders,
delivered to
healthcare
professionals
on outcomes
of care.

19 took place
in the US in
outpatient
settings

Kaczorowski, J.,
Goldberg, O., & Mai,
V. (2011). Pay-forperformance
incentives for
preventive care.
Canadian Family
Physician, 5

Descriptive study
Identification
of the attitudes
and strategies
of physicians
regarding
preventative
care delivery
before and
after they
participate in
The Provider
and Patient
Reminders in
Ontario; MultiStrategy
Prevention
Tools (PPROMPT)

246 physicians
from 24
primary care
network/family
health network
groups,
located in 110
different sites.

process adherence
of 4.2% across all
reported process
outcomes, 3.2% for
vaccinations

26 were
randomized
trials and 6
comparisons
were quasirandomized
design

Pre and Post
intervention
surveys given to
physicians.
Pre-intervention
survey consisted of
18 questions, each
scored on a 7-point
Likert scale
Information
collected on
preventive care
practices and
physician’s
opinions regarding
prevention.
Physician
demographics were
also included.

Physician and patient reminders
were noted to be perceived by
providers as being useful to their
practices.

Level
III/Grad
eB
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Post-intervention
survey included the
same 18 baseline
questions with an
additional 13
questions regarding
how useful the PPROMPT tools and
services.

Koch, J. A. (2012).
Strategies to
overcome barriers to
pneumococcal
vaccination in older
adults: An integrative
review. Journal of
Gerontological
Nursing, 38(2), 31-39.
doi:10.3928/00989134
-20110831-03

To assess
effective
strategies on
improving
pneumococcal
vaccination
rates in the
older adult
population

Integrative
Review

P-PROMPT
services included
physician and
patient reminders
as well as office
management tools
and administrative
database
integration.
11 studies
Multiple studies
were included
noted that
in the review
physician offices
including
that implemented
Descriptive
vaccination
studies, RCT’s, implementation
and Quasistrategies (prompts
experimental
on patient charts,
studies
immunization
tracking systems,
and designated
vaccination clinics)
were associated
with increased
pneumococcal
vaccinations.

System-wide changes such as
Level
standing orders, computerV/Grad
generated provider reminders in
eA
combination with patient
reminders are needed to increase
pneumococcal vaccination
uptake
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Mohammed, H.,
McMillan, M., Roberts,
C., & Marshall, H.
(2019). A systematic
review of interventions
to improve uptake of
pertussis vaccination
in pregnancy. Plos
One, 14(3), 1-14
doi:10.1371/journal.po
ne.0214538

Ruffin, M., Plegue, M.,
Rockwell, P., Young,
A., Patel, D., &
Yeazel, M. (2015).
Impact of an electronic
health record (EHR)
reminder on human
papillomavirus (HPV)

To obtain
evidence
regarding
improvement
of pertussis
vaccination
rates in
pregnant
women and
effective
strategies to
improve those
rates

To assess the
effectiveness
off an EHR
alert to
increase HPV
vaccination
series
completion

22

Systematic
Review

-Two were
retrospective
studies
focused on
provideroriented
interventions

A descriptive study
noted that there
were higher
percentages of
immunization with
the pneumococcal
vaccine with
provider reminders
(77%)
Two retrospective
cohort studies; one
included a “best
practice alert” to
alert providers to
offer maternal
pertussis
vaccination. Postimplementation
indicated that
immunization rates
improved to 97%
compared to 48%
pre intervention.

-One
observational
prospective
study
Two cohorts(
prompted and
unprompted) of
females
between the
ages of 9-26
years

Providers received
a prompt that the
patient was due for
the HPV vaccine
and indicated which
dose they were due
for.

Six studies
included
-Three were
randomized
control trials

Retrospective
Cohort

Implementation of a “best
practice alert” within the EHR has
been associated with increased
influenza vaccination rates and
can be generalized to pertussis
vaccinations.

Level
I/Grade
B

Significantly more patients
initiated the vaccine in the
prompted cohort (34.9%) than in
the unprompted cohort (21.5%)
(p<0.001).

Level
III/Grad
eA

The prompted cohort was
significantly more likely (p<0.001)
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vaccine initiation and
timely completion.
Journal of the
American Board of
Family Medicine,
28(3), 324-333.
doi:10.3122/jabfm.201
5.03.140082
Tan, L. (. J. ). (2018).
A review of the key
factors to improve
adult immunization
coverage rates: What
can the clinician do?
Vaccine, 36(36),
5373-5378.
doi:10.1016/j.vaccine.
2017.07.050
Zimet, G., Dixon, B.
E., Xiao, S., Tu, W.,
Kulkarni, A., Dugan,
T., . . . Downs, S. M.
(2018). Simple and
elaborated clinician
reminder prompts for
human papillomavirus
vaccination:
A Randomized clinical
trial. Academic
Pediatrics, 18(2), S66S71.
doi:10.1016/j.acap.20
17.11.002

To discuss
healthcare
providers best
practices to
improve
vaccination
rates

Review

To assess the
effects of a
simple versus
elaborated
computerized
reminder
prompt on the
HPV
vaccination
rate

Randomized
clinical trial

Total of 5,994
eligible
females in the
prompted
cohort and
9,027 eligible
females in the
unprompted
cohort
Multiple
interventions to
increase
vaccination
uptake as well
as reducing
patient out of
pocket costs
for
vaccinations
29 pediatric
HCP’s were
randomized to
1 of 3 arms of
the
intervention:
a. Usual
practice control
b. Simple
reminder
prompt
c. Elaborate
reminder
prompt
(included
suggestive
language for

to complete the vaccination
series than those in the
unprompted cohort.

Provider reminders that prompt
Level
the provider that a patient is due
V/Grad
for a specific vaccination can help e B
to increase vaccination rates.

Control group: ten
HCP’s saw 301
patients
Simple prompt: 8
HCP’s saw 124
patients
Elaborated prompt
saw 223 patients
and had a higher
rate of HPV
vaccination (62%)
than the control
(45%) adjusted
odds ratio, 2.76,
95% CI, 1.07 to
7.14.

An elaborated prompt to
healthcare providers significantly
increased HPV vaccination
uptake than the simple prompt or
control group.

Level
1/Grad
eA
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recommendati
on of vaccine)

The simple prompt
did not retrieve
significant results.
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Levels of Evidence
The Johns Hopkins Nursing Evidence-Based Practice (JHNEBP) tool was used to level
and rate the evidence for this project. Within this model, evidence falls under five levels labeled
I-V and given a quality rating of A-C. Level I evidence includes experimental studies,
randomized control trials (RCT), explanatory mixed method designs that include only a level I
quantitative study, and systematic reviews of RCTs, with or without meta-analysis. The quality
rating of A is considered high quality with consistent and generalizable results. A quality rating
of B is considered good quality with reasonably consistent results and a sufficient sample size
for the study design. A quality rating of C is considered low quality or with major flaws and little
evidence with inconsistent results (Dang & Dearholt, 2017)
According to the tool, level II evidence includes quasi-experimental studies and
explanatory mixed method designs that include only a level II quantitative study. This level also
includes systematic reviews of a combination of RCTs, quasi-experimental studies, or quasiexperimental studies only, with or without meta-analysis (Dang & Dearholt, 2017). Level III
evidence includes nonexperimental studies, exploratory, convergent, or multiphasic mixed
methods studies, explanatory mixed method designs that include only a level III quantitative
study, qualitative studies, and meta-synthesis. This level also includes systematic reviews of a
combination of RCTs, quasi-experimental and nonexperimental studies, or nonexperimental
studies only, with or without meta-analysis (Dang & Dearholt, 2017). The quality ratings for
levels II and III are the same. Quality rating of A/B is considered high/good quality if the
following are found in the studies: (a) transparency, (b) diligence, (c) verification, (d) selfreflection and scrutiny, (e) participant-driven inquiry, and (f) insightful interpretation. A quality
rating of C refers to studies that have little contribution to the overall review and few or none of
the above features for high/good quality (Dang & Dearholt, 2017).
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Level IV evidence includes studies that incorporate the opinion of respected authorities
and/or nationally recognized expert committees or consensus panels based on scientific
evidence. These include clinical practice guidelines and consensus panels/position statements.
Quality ratings for this level are labeled A-C. Quality level A refers to high quality that the
material is officially sponsored by a professional, public, or private organization or a government
agency. The material has consistent results as well as enough numbers of well-designed
studies. Level B refers to good quality and includes a reasonably thorough and appropriate
systematic literature search strategy, reasonably consistent results, and enough numbers of
well-designed studies. Level C refers to low quality or major flaws in which the material is not
sponsored by an official organization or agency and is poorly defined, undefined, or a limited
search strategy. Conclusions cannot be drawn at this level (Dang & Dearholt, 2017).
Level V evidence is based on experiential and non-research evidence including literature
reviews, integrative reviews, quality improvement, program, or financial evaluation, case
reports, and the opinion of recognized experts based on experiential evidence. Quality ratings
for this level are labeled A-C as well. For quality improvement, program or financial evaluation
studies, level A refers to high quality with clear aims and objectives and consistent results
across multiple studies. Level B refers to good quality with clear aims and objectives with
consistent results in a single setting. Level C includes studies with unclear or missing objectives,
inconsistent results, and recommendations cannot be made (Dang & Dearholt, 2017). Quality
ratings for integrative reviews, literature reviews, expert opinion, case reports, community
standards, clinician experience, and consumer preference include Level A which refers to high
quality. Within this level, evidence of expertise and conclusions can be drawn. Level B refers to
good quality meaning the expertise appears to be credible and conclusions drawn are definitive.
Level C refers to low quality or major flaws in which expertise is not credible and conclusions
cannot be drawn (Dang & Dearholt, 2017).
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Appraisal of Relevant Evidence
Level I evidence.
Francis et al (2017) performed a systematic review through a comprehensive search
through five databases and required specific inclusion and exclusion criteria. In order to be
included in the review, studies had to (a) test the efficacy of an HPV vaccination intervention
that focused on initiation of the vaccine, uptake or completion; (b) measure initiation of vaccines,
uptake or completion rates as a dependent variable, (c) use computer, internet or mobile
technology (text messaging, desktop or laptop computers, interactive videos, internet, or health
information technology) in the development or delivery of the intervention; (d) use an
experimental design that individuals were randomized to at least one computerized and one
comparison condition. Studies excluded from the systematic review included those that included
historical controls (Francis et al (2017). Twelve studies were included in the review and each of
the studies was summarized for easy access in the review. The studies were explained based
on their inclusion criteria (vaccination initiation and completion, vaccination outcomes by target
audience; patients, parents, or providers). Nine out of the 12 studies concluded that initiation of
the vaccine was higher with communication technology interventions. Telephone calls were
noted to have a 16% increase in HPV doses one and two. There was a three percent increase
in patients receiving the first dose of the vaccine and one percent increase in dose two, utilizing
the central text messaging system. The authors noted a three percent increase in HPV
vaccination rates among college students utilizing interactive computerized videos. Series
completion was reported in 10 of the 12 studies. There was a 13% increase in completion
utilizing EHR prompts and telephone calls and an eight percent and 12% increase with EHR
prompts only and telephone calls only respectively (Francis et al, 2017). Studies that targeted
patients only were noted to have mixed results. Interactive computer videos were noted to have
higher immunization rates on at least one of the outcomes (dose initiation or series completion)
(Francis et al, 2017). Studies also showed mixed results when only providers were targeted and
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EHR prompts were used. One of the provider-only studies saw that the series completion was
significantly higher for the prompt and another study did not show any difference with the
prompt (Francis et al, 2017). The authors concluded computer generated prompts as well as
reminders are significant interventions in helping providers and parents endorse the HPV
vaccine (Francis et al, 2017). Furthermore, Frances et al (2017) note that “given the increasing
use of electronic health records to improve vaccination rates, developing and testing
interventions that can proactively target providers and patients at the time of appointment
should be a high priority” (p. 1285). While the review explained the search strategy as well as
the results thoroughly, the authors did not include which specific studies correlated with which
results. While the study was useful and Level I evidence due to the systematic review of RCTs,
it was rated Grade B based on the JHNEBP criteria, as the reader can draw reasonably
consistent conclusions from the results. This study was included due to an eight percent
increase in vaccination rates with the provider prompt alone. While it may not have been the
highest percentage intervention, it is still deemed relevant for purposes of this EBP project.
Humiston et al (2011) performed an RCT that assessed patient tracking, recall,
outreach, and provider prompts to increase influenza vaccination rates in several primary care
centers (PCC). The study included a variety of participants of different ethnic and racial
backgrounds and comprised an adequate sample size of 170 participants for each group
(control and intervention). The control group received the standard of care which consisted of
each office’s routine immunization practice. The intervention group received patient tracking
which consisted of patient chart reviews focused on immunization status by outreach workers
and provider reminders that flagged patient charts with a brightly colored paper that stated
“REMEMBER! This patient needs influenza vaccine” (Humiston et al, 2011, p 42). The
intervention also included patient reminders. These reminders included mailed reminders to
patients as well as telephone patient reminders performed by outreach workers. The primary
outcome measure was receipt of the influenza vaccination. The intervention group was noted to
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have a 62% vaccination rate compared to the control group of 22%. Humiston et al (2011) noted
that the intervention group was six times more likely to receive the vaccination than patients in
the control group (OR=6.25; 95% CI 5.41, 7.22, p <0.0001). The results were clearly
differentiated and easy to follow. While this RCT was concluded to be Level I, Grade A based
on JHNEBP criteria, the study focused on a population of senior aged urban residents.
However, results are likely to be generalizable to the population for this project. This study was
included due to the increase in vaccination rates with provider reminders. While the study
utilized patient reminders by mail and telephone calls, these interventions were not applicable to
this project because at the SHC, permission was not given for this project for access to the
patient’s demographic data such as address and telephone number. However, marketing
strategies such as posters will be placed around campus to target students who do not utilize
the SHC frequently, with the intention to compensate for the inability to contact students directly.
Mohammed, McMillan, Roberts, & Marshall (2019) conducted a systematic review that
focused on interventions to improve pertussis vaccination uptake in pregnant patients. Six
studies were included in the review that included two RCTs considered moderate or low, as well
as two retrospective cohort studies. These studies included provider focused interventions such
as an electronic “best practice alert” (Mohammed, McMillan, Roberts & Marshall, 2019, p 6) to
the provider to offer the pertussis vaccination to the pregnant mother. Results concluded that
there was a significant improvement of vaccination uptake post-intervention: 97% compared to
preintervention of 48% (Mohammed, McMillan, Roberts & Marshall, 2019). Two of the RCT
studies focused on modalities specific for the pregnant woman that included an affective
messaging video and an iBook cognitive messaging intervention without significant results, 6%
and 7% respectively (Mohammed, McMillan, Roberts & Marshall, 2019). Further studies also
assessed bundled interventions that utilized iPads given to obstetric patients in examination
rooms that were pre-populated with education on the importance of maternal immunization. This
was paired with implementation of a vaccine champion who kept vaccines stocked in the office
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to see if there was a difference in vaccine rates. The results indicated that there was an
increase in pertussis vaccinations overall utilizing the multi-component program, but the results
were not significant (RR 1.58, 95% CI 0.81, 3.07). This review indicates that a computerized
best practice alert is an ideal intervention to aid in increasing uptake of the pertussis
vaccination. The results of the review clearly stated recommendations for increasing pertussis
vaccination in the pregnant population. While this review focuses on a different population than
this project, the results may be generalizable to vaccinations, therefore deemed useful. Based
on JHNEBP criteria, this was rated Level I, Grade B as the results were reasonably consistent.
Zimet et al (2017) conducted an RCT that evaluated a simple versus elaborated
computerized provider prompt to increase HPV vaccination rates. A simple prompt included a
general statement (“vaccines to consider today”) (Zimet et al, 2017, p 68) for the provider to
assess the vaccinations that should be considered during the visit. The elaborated prompt
included a suggested script (“these vaccines are recommended for (patient name),
meningococcal to prevent meningitis, HPV to prevent cancer….”) (Zimet et al, p 68) prompted to
the provider to say during the visit. The authors found that the elaborated prompt increased
HPV vaccination rates to 62% as compared to 45% prior to the intervention (OR, 2.74, 95% CI,
1.06-7.05, p=.036). Zimet et al (2017) did account for patient sex and race/ethnicity using an
adjusted odds ratio (AOR), still finding significant results for the elaborated prompt (AOR, 2.76’
95% CI, 1.07-7.14). During this study, there was an adequate sample size as well as consistent
results making it generalizable to similar settings and given a rating of Level I, grade A based on
JHNEBP criteria. This study was utilized for this project due to the significant increase in
vaccination rates with the provider prompt which is the primary intervention for this EBP project.
Level III evidence.
Arditi et al (2017) conducted a systematic review that included 35 studies; 30 of which
were RCTs and five were nonrandomized studies therefore it is considered level III. This review
aimed to assess the effects of a computer-generated reminder to healthcare providers on
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healthcare outcomes and provider practices. These outcomes included effect on vaccination
rates, test ordering, follow-up rates, prescription rates, and overall compliance rates for the
providers (Arditi et al, 2017). The authors performed a systematic search of multiple electronic
databases including CINAHL, Medline and Cochrane as well as performing a hand search for
relevant studies. The authors included a study flow diagram for readers to visualize their search
which was helpful to examine their workflow. Primary outcomes were related to quality of care
including percentage of HCP’s ordering a specific test or prescription as well as the HCP’s
compliance with guidelines such as ordering a breast cancer screening for eligible patients or
vaccine screenings (Arditi et al, 2017). Secondary outcomes measured were related to patient
outcomes such a diabetic glycemic control as well as continuous patient measures such as
blood pressure and body mass index (Arditi, 2017). The studies assessed the effect of a
computer reminder delivered on paper on the HCP’s behavior and compliance of the above
primary and secondary outcomes. The authors found that there was an almost seven percent
improvement in quality of care outcomes related to a computer -generated reminder delivered
on paper as well as a co-intervention which was considered the standard of care, pertaining to
test ordering rates, prescriptions, and vaccination rates (Arditi, 2017). The study found that the
reminder alone increased quality of care outcomes by 11%. Therefore, it can be concluded and
generalizable that a computer-generated reminder delivered on paper can increase HCP’s
compliance with ordering specific tests as well as vaccinations. However, due to methodological
limitations in the review, the evidence included was deemed to be low certainty, so this study
was given a Grade C based on JHNEBP criteria. This study was included as a provider
reminder delivered on paper is deemed more feasible within the SHC for purposes of this EBP
project. The study also had positive results related to provider compliance rates increasing with
vaccinations due to the reminder.
D’Agostino (2016) performed a non-randomized intervention control study that is
considered level III. This study focused on EHR provider prompts to increase pertussis
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immunization rates. Within this study, there were 120 EHR records (60 included in the
intervention group and 60 included in the control group) selected for the sample the utilized
prompt in the chart to notify the provider to acknowledge the patient’s vaccination history
(D’Agostino, 2016). The reminder was visible to the HCP clearly once they opened the patient’s
chart. The primary outcome that was measured was the administration of the pertussis
vaccination. A retrospective chart review was completed to assess preintervention vaccination
rates (D’Agostino, 2016). Prior to the intervention, pertussis vaccination rates were at 1.4%.
HCP’s who received the clinical reminder vaccinated 8.3% of eligible patients compared to
those who did not receive the reminder who only vaccinated 5% of their eligible patients. The
author stated that the results were inconclusive but suggested that the reminder may be an
effective strategy if there was a larger sample size of patients and providers as well as
increased primary care sites (D’Agostino, 2016). Due to the inconclusive results, this study was
given a Grade C, but will still be used as this project could have a higher sample size and the
different setting could increase immunization rates with this strategy.
Jaca et al (2018) performed a systematic review that focused on strategies to reduce
missed opportunities for vaccination (MOV). The search methods were clearly stated that
included RCTs and cohort studies giving this review a level III. The inclusion criteria for this
review were inclusion of participants that were: (a) eligible for vaccinations, (b) caregivers of
individuals eligible for vaccinations, and (c) healthcare workers responsible for providing
immunization services (Jaca et al, 2018). Specific search criteria were explained, and the
authors utilized a grading system for each piece of evidence. There were six studies deemed
relevant in this review. Outcomes that were measured included decreasing MOV’s and
increasing vaccination rates. There were multiple interventions discussed in each of the studies
including provider prompts with or without tracking. One portion of the intervention included
nursing screening EHR’s for immunization needs and placing a MOV sticker on the patient’s
chart in need of a vaccination. The tracking portion of the intervention included the provider
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prompt and healthcare workers sending postcards, telephone calls, or performing home visits
to remind the patients to receive their vaccinations. Another study utilized a brightly colored
vaccination card placed on the front of the patient’s chart. Additional interventions in multiple
studies included case management following up with patients via telephone, postcards, or home
visits when immunizations were due, chocolate bars which were given to physicians that were
labeled with “immunize on time” (Jaca et al, 2018, p 2924). The authors indicated that overall,
the evidence suggest that patient education, patient tracking, outreach, and provider prompts
reduce MOV’s and improve vaccination rates. This study deemed the evidence moderate to low
due to wide confidence intervals. The authors also noted an increased risk of bias due to
outcome assessors unable to be blinded as well as incomplete outcome data (Jaca et al, 2018).
The results given may still be applicable to this project as the nurse screened the charts for
vaccination status, which will be part of the intervention included in this project. The study also
included a brightly colored reminder to the provider on the patients’ chart, that the patient needs
a vaccination which will be utilized for this project. Telephone calls and postcards are not
applicable to this EBP project as permission for access to these items was not granted within
the SHC.
Ruffin et al (2015) conducted a retrospective cohort study (level III) that assessed the
effect of a computerized prompt versus no prompt in the EHR on HPV vaccinations. There were
6,019 eligible patients for the vaccine in the prompted cohort and 9,096 vaccine eligible patients
in the unprompted cohort. The primary outcome measured was initiation and completion of the
HPV vaccination series as well as the time between each vaccination (Ruffin et al, 2015). The
study indicated that more eligible females initiated the HPV vaccination series in the prompted
cohort group (35%) compared to the unprompted group (21.3%). The authors noted that the
prompted cohort had significantly higher odds of completing the vaccination series than the
unprompted cohort. However, the authors did not offer numerical data regarding that
component. Ruffin et al (2015) noted that the prompted cohort patients were significantly more
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likely (p<0.001) to receive all three doses in the vaccination series on time. Ruffin et al (2015)
demonstrated diligence as they gathered multiple studies to retrieve evidence related to the
intervention as well as transparency in that the eligibility criteria, study setting, and analytic
variables were well described, given this a Grade A. The results were conclusive and
generalizable making this an asset to the body of evidence for this project. The study was useful
as it shows an increase in vaccination rates with the use of a provider reminder which is the
primary intervention for this project.
Shojania et al (2009) conducted a systematic review that concentrated on processes
and outcomes of care due to on-screen, point of care reminders. The study yielded 28 studies
that met the inclusion criteria of (a) having a reminder system that is routinely used by
clinicians, (b) randomized or quasi-randomized design, and (c) at least one outcome consisting
of a clinical endpoint or adherence to a care recommendation (Shojania et al, 2009). The study
was determined to be level III based on JHNEBP criteria. Primary outcomes measured in this
review include process adherence of HCP’s in ordering medications, vaccination
recommendations, and test ordering. The results concluded that the intervention of on-screen,
point of care reminders impacts provider adherence modestly. For instance, medication ordering
was increased by 3.3%, adherence to vaccine recommendations was increased by 3.8%, and
test ordering by 3.8% (Shojania et al, 2009). The study clearly describes the information found
including methods of reporting the effect sizes across groups of studies. Shojania et al (2009)
also demonstrated insightful interpretation based on JHNEBP criteria as the data correlated with
what was known about the intervention of on-screen computer reminders. The results did not
reveal what specific reminder had the best outcome, therefore given a Grade B. The study can
be generalized however, therefore was kept for this project due to an increase in provider
adherence to vaccination recommendations related to the provider reminder, which is the basis
of this project.
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Level V evidence.
Daly, Halon, Aronowitz, & Ross (2016) published a quality improvement program that
was determined to be level V evidence. The primary objective of the study was to increase HPV
vaccination rates among university students. The study was given a Grade B, as the results
were consistent in a single setting (university) and scientific evidence is referenced, as there
were multiple studies reviewed and interventions from the evidence were utilized. These
interventions included (a) prevent missed opportunities to vaccinate by increasing provider
acknowledgement of vaccine history, (b) provide a strong recommendation for vaccination at
every visit, (c) utilize patient reminder systems, and (d) utilizing marketing strategies on campus
(Daly, Halon, Aronowitz, & Ross, 2016). Daly, Halon, Aronowitz, & Ross (2016) noted that
46.5% of total patient visits during the 16-weeks that the study was conducted, met inclusion
criteria. During this time period, 158 HPV vaccines were given to 120 individual patients (Daly,
Halon, Aronowitz, & Ross, 2016). This demonstrated a 13-fold increase in vaccination rate
during this program. The participants were of a variety of race and ethnic backgrounds
indicating generalizability in other settings. The provider acknowledged the vaccination history in
92% of the visits (Daly, Halon, Aronowitz, & Ross, 2016).The study did not give a specific,
numeric significance level, however 92% was considered significant according to the authors.
This study was kept due to the variety of participants as well as the high success rate. This EBP
project will utilize providing strong recommendations by the provider for vaccination as well as
marketing strategies around campus such as educational posters adapted from the CDC to help
increase vaccination rates. The project will not be utilizing patient reminders as access to
patient contact information such as email, telephone numbers, and addresses are not permitted.
Grivas et al (2016) conducted an experimental study as part of a quality improvement
project at a cancer center that was determined to be level V evidence. Grivas et al (2016)
implemented a quality improvement program to increase influenza vaccination rates. Multiple
interventions were employed including a pre-printed vaccination prescription alerting the
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providers to address vaccination history, a best practice alert in the EHR, and a laminated
reminder on the chart and clinic workstations regarding the vaccine. A bright pink sticker was
placed on the patient’s medication reconciliation list as well indicating need for vaccination.
Educational reminders were placed around the cancer center to remind patients to obtain their
influenza vaccine. The study was given a Grade B based on JHNEBP criteria as the aims and
objectives were clearly stated and the results were consistent in a single setting (cancer center).
Reasonably consistent results were noted as the intervention corresponds to findings from
similar studies (Grivas et al, 2016). The results indicated there was a 37.6% increase in adult
vaccination rates during the 2011-1012 season , and a 56.1% increase in vaccination rates for
the 2012-2013 influenza season (95% CI 40.9-73%). These seasons were compared to
previous seasons starting from the 2005-2006 season through 2010-2011 influenza season.
The article was kept as it demonstrated clear results that can be generalized to the population
specific to this project. Educational marketing strategies will be placed around campus as a
reminder to patients to receive their Men-B vaccination. A laminated reminder will also be
placed on the computer workstations in the SHC to remind staff to screen for vaccination history
and for the providers to educate and offer the vaccination.
Koch (2012) conducted an integrative review, level V evidence, regarding strategies to
overcome barriers to the pneumococcal vaccination in older adults. The author researched
multiple databases to explore studies relevant to the topic. Exclusion criteria were developed as
follows: (a) studies conducted solely outside of the United States, (b) interventions initiated in
the emergency room, (c) studies that included barriers without evaluation of an intervention or
strategy, and (d) outcomes other than vaccination rates (Koch, 2012). It was noted that there
were inconsistent results between two studies in the literature regarding provider reminders to
increase pneumococcal vaccinations. However, Koch (2012) surmises that the intervention of
provider reminders holds promise to assist in increasing vaccination rates. The author noted
that there was evolving evidence that multicomponent interventions such as standing orders,
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computer-generated provider reminders, and patient reminders were needed to increase
pneumococcal vaccine practices into routine care. This review was given a Grade A based on
JHNEBP criteria, as the authors expertise is evident and definitive conclusions can be drawn.
Scientific rationale is also a contributor to the grading, as multiple studies were appraised and
conclusions regarding the intervention being successful can be drawn. This integrative review
was included for this EBP project as there were consistent results in the increase of vaccination
rates related to provider reminders which is the primary intervention of the project.
A review deemed level V evidence, conducted by Tan (2017) addressed clinician
interventions to improve adult immunization rates. Tan (2017) included interventions in the
review that were comprise of (a) enhancing patient access to the vaccine, (b) reducing out of
pocket costs for vaccinations, (c) improving community/patient demand, and (d) clinician
focused interventions (patient reminder and recall systems, provider reminders, provider
assessment and feedback, and standing orders in EHR) The review was determined to be
Grade B based on JHNEBP criteria as the author did not provide the studies in which the
findings were derived. The review draws definitive conclusions based on the findings. Findings
indicated that reminders, such as notes placed in the patient’s chart alerting providers, EHR
best practice alerts for providers, or memos sent to patients through email or mail can be
effective in increasing vaccination rates. Standing orders are also considered to assist in
increasing vaccination rates as nurses and other healthcare providers can assess the need for
vaccination and administer immediately without the physician directly involved in the interaction
(Tan, 2017). There are not many studies reviewed, but Tan (2017) noted positive findings
regarding the interventions of provider reminders, patient reminders, and implementation of a
standing order protocol. This review was included for this project due to the multiple ways of
delivering a provider reminder for vaccinations, that were said to be successful. Education to the
patients was also said to be effective. This project is to include a provider reminder on the
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provider and staff laptops as well as and educational handout to the patients regarding the
specific vaccination.
Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
After critical review and appraisal of the literature, there were several common themes
noted within the studies. The commonalities served to build the best practice recommendation
for this project. The studies included for appraisal and synthesis incorporate a theme of provider
reminders, best practice alerts, laminated clinician reminders, patient educational efforts, and
marketing strategies. Four studies indicated that an on-screen provider reminder to prompt the
physician to assess vaccination status in the EHR was noted to increase vaccination rates
(Shojania et al, 2011; Ruffin et al, 2015; D’Agostino, 2016; Francis et al, 2017; Zimet et al,
2017). Two studies indicated that multicomponent strategies including the assessment of
vaccination status, vaccine education delivered to the patient prior to seeing the provider, a
sticker or a paper reminder placed on the patients chart reminding the provider to inquire about
the recommended vaccinations (Jaca et al, 2018; Humiston et al, 2011; Tan et al, 2017). One
study found that the addition of a marketing strategy such as a poster campaign on campus also
impacted vaccination rates (Daly, Halon, Aronowitz, & Ross, 2016).
Francis et al (2017) concluded that a reminder or prompt for the provider appeared to
increase HPV vaccination rates by 8% for series completion as it served as a communication
tool between the provider and parents or patients. Similarly, D’Agostino (2016) also found that a
provider prompt in the EHR that cue’s the physician to acknowledge the patient’s vaccination
history and provide recommendations for vaccination increased pertussis vaccination rates by
8.3% compared to 5%.
Ruffin et al (2015) concluded that a prompted cohort reminder increased HPV
vaccination initiation rates (35%) than an unprompted cohort (21.3%). The prompted cohort was
noted to have “significantly higher odds of completion when compared with the unprompted
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cohort for all levels of covariates” (Ruffin et al, 2015, p 328). Zimet et al (2017) also noted that a
prompt in the chart correlates to an increase in HPV vaccination rates. This study focused on a
simple prompt that alerted providers to vaccines to be considered during that visit versus an
elaborated prompt that consisted of a suggested script and prompted the provider to look at
vaccination history and recommend vaccinations based on patient data. The elaborated prompt
had a 62% vaccination rate compared to the control group with 45% (Zimet et al, 2017).
A quality improvement program to increase HPV vaccination rates conducted by Daly,
Halon, Aronowitz, & Ross (2016) noted that an EHR prompt to give the providers a visual cue to
acknowledge the patient’s vaccination history. Within the EHR, a hard stop was developed,
whereby the provider must click on “yes or no” in order to move on to the patient’s chart. This
program indicated that there was a significant increase in HPV vaccinations due to the EHR
prompt as 158 vaccinations were given to 120 individual patients.
Humiston et al (2011) conducted an RCT to increase adult influenza vaccinations noted
that a combination of a paper reminder in the physical chart as well as patient outreach through
a letter or a card increased vaccination rates significantly (p<0.0001) (Humiston et al, 2011).
Likewise, Grivas et al (2016) compared a best practice alert in the chart for patients who had yet
to receive the influenza vaccination, as well as a laminated reminder placed on the patient’s
physical chart. Despite provider feedback stating that the laminated reminder (70%) was more
helpful than the best practice alert (36%) (Grivas et al, 2016), the best practice alerts were
demonstrated to result in increased vaccination rates. Mohammed, McMillan, Roberts, &
Marshall (2019) noted in a systematic review that a best practice alert to the provider in the EHR
improved pertussis vaccination uptake in pregnant women to 95% when compared to the 48%
prior to the intervention. Tan (2017) also noted that provider reminders including best practice
alerts, notes posted in the patients EHR, and memos to the provider can improve immunization
rates.
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The appraisal and synthesis of these relevant studies indicates that a multicomponent
strategy was necessary to increase providers’ adherence to vaccination recommendations, as
well as increase vaccination rates for multiple preventable diseases. Engaging the provider and
the patient was deemed most impactful to the primary outcome of increased vaccination rates.
The components of the strategy include different forms of provider reminders at time of patient
visit, patient education prior to seeing the provider, and campus-wide vaccination campaigns.
Best Practice Model Recommendation
The best practice recommendation was based on the collected evidence. There is
utmost importance to keep patient’s up to date with their immunizations. If the public is
immunized, then the risk of spreading disease will be decreased, therefore preventing
hospitalizations, morbidity, and mortality. Evidence suggests that a multicomponent strategy is
essential to increase vaccination rates. The strategy for this EBP project included a brightly
colored reminder on each of the five provider laptops utilized by staff at the SHC including the
physician, APN, MA, and RN that states “REMEMBER! To offer and order the Men-B
vaccination”. The MA or the RN assessed the patient’s vaccination status and for the following
inclusion criteria: (1) not an incoming student, (2) under the age of 23, and (3) have not received
Men-B vaccine. Once criteria were met, a CDC educational brochure regarding meningitis and
the Men-B vaccine was given to the patient by the MA or RN while they were waiting in the
examination room. Once the provider entered the examination room, the provider emphasized
the information on the handout and educate the patient. Once this was done, the provider asked
the patient if they were interested in the Men-B vaccination, if they said yes, the provider then
provided further education and ordered the vaccination. The vaccine was administered by the
MA or the RN. If the patient stated “no”, then the education from the CDC was emphasized still
regarding the increased risk and the student was educated that they could walk in at any time to
receive the vaccination. Marketing strategies were also utilized including posters (Appendix B)
adapted from the CDC which were placed across campus in key student meeting locations,
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including the student union, residence halls, sorority houses, and in the waiting room of the
SHC.
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CHAPTER 3

IMPLEMENTATION OF PRACTICE CHANGE
Chapter three corresponds to phase IV of the Stetler model: translation/application.
Evidence has shown that the application of a multicomponent strategy has had a positive effect
on increasing vaccination rates. Jaca et al (2018) assessed the effect of a multicomponent
intervention to increase vaccination rates. They note that a nurse would screen the patients
charts for vaccination histories no matter the reason for visiting the provider as well as
educating the patients prior to the visit regarding the specific vaccinations and disease
processes. Once vaccination need was identified, a sticker was placed on the patient’s chart
indicating the need for a specific vaccination to remind the provider to offer the vaccination as
well as educate the patient regarding the vaccinations (Jaca et al, 2018). Similarly, Humiston et
al (2011) found that outreach workers in a clinic, tracking patients immunization statuses as well
as a paper reminder placed in the patient’s physical chart reminding the provider to offer
immunization also significantly increased vaccination rates. Tan et al (2017) also identified that
a combination of a provider reminder on paper posted in the physical chart or in the EHR as well
as education given to the patients prior to their visit also increased vaccination rates. Grivas et
al (2016) note that a laminated reminder placed on the patient’s physical chart was helpful to
providers to prompt them to assess vaccination history and offer due vaccinations. Mohammed,
McMillan, Roberts, and Marshall (2019) note that a multicomponent intervention of a best
practice alert in the EHR to remind the provider to offer vaccination as well as education in the
examination room to the patient via I-Pad on the importance of vaccination also has shown an
increase in vaccination rates. Multiple studies indicate that an on-screen provider reminder to
prompt the physician to assess vaccination status in the EHR was also noted to have a positive
effect on increasing vaccination rates (Shojania et al, 2011; Ruffin et al, 2015; D’Agostino, 2016,
Zimet et al, 2017). Furthermore, marketing strategies such as educational posters adapted from
the CDC placed in student areas such as bathroom stalls across a college campus as well as

MENINGOCOCCAL PROTOCOL

43

outreach events including wellness fairs have also shown to aid the increase of vaccination
rates (Daly, Halon, Aronowitz, & Ross, 2016). The purpose and application of this EBP project
was to identify if the use of a provider reminder combined with a poster campaign and education
to the students would influence Men-B vaccination rates.

Participants and Setting
The EBP project took place in an SHC at a midwestern university. Within this EBP
project, there are many key stakeholders that were an essential part of the implementation of
this practice change. At this specific SHC, there was a part-time physician, one full-time APN,
one part-time APN, one registered nurse (RN), and a medical assistant (MA). Their participation
in this project was essential as the MA and RN were responsible for reviewing vaccination
histories and providing the educational brochure to students. The physician and the APN were
also essential as they were validating the education, offering the Men-B vaccine to the students,
and placing the vaccine order into the EHR if applicable. The eligible patients included (a) nonincoming students, already enrolled in the university, (b) age 23 and under, (c) students who
have not yet received the Men-B vaccine previously.
Pre-Intervention Group Characteristics
When speaking with the SHC director, it was noted that beginning Fall 2019 semester, it
would be mandatory for all incoming students aged 23 and under to have had the Men-B
vaccination prior to attending the university. With that in mind, freshmen as well as first time
students were excluded from this EBP project. According to the CDC (2019), young adults aged
16-23 years old are most susceptible to the Men-B disease. For this project, established
students 23 years of age and younger were targeted. The students could be undergraduate or
graduate students.
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Intervention

Evidence suggested that a provider reminder placed on the patient’s physical charts,
regarding recommendation of vaccinations, increases vaccination rates. Evidence also
suggested that a poster campaign as well as education also influences vaccination rates. For
this EBP project, a brightly colored reminder placed on each of the clinics five laptop computers,
utilized by the MA, RN, physician, and APN’s that states “REMEMBER! To offer and order the
Men-B vaccination” was implemented. The colors and placement of the reminder on the laptop
were changed out every two weeks to keep the staff alert to the reminder. A poster campaign
was also utilized in frequently used buildings by the students. For example, the student union,
sorority houses, and residence halls had posters placed regarding the Men-B disease and the
vaccine. The workflow was reviewed with each staff member. Once a student came in, whether
for an already scheduled appointment or walk-in, the MA or RN screened each patient’s chart
for the specified criteria (a) 23 years of age and under and (b) has not received the Men-B
vaccine previously. Once the patient was brought to the examination room by the MA or RN, if
the patient met criteria, they were notified that they are eligible to receive the vaccine and they
were asked if they would like to receive the vaccination or if they would like more information
regarding it. If the student stated yes, then an educational handout with information from the
CDC was placed in a box directly outside of the examination room. This signaled to the provider
that the student was interested in the vaccination and would prompt them to educate the
student. Once in the examination room, the provider gave the student the educational handout
and provided education regarding the Men-B disease and vaccination. If they accepted, then the
provider ordered the vaccination in the EHR and the immunization was given by the MA or RN.
If the patient declined at the beginning of the visit, the MA or RN would give them an
educational brochure that also contains information from the CDC about the disease and
vaccination to read and take with them. The student was also notified that they could call to
make an appointment or walk in to receive the vaccination later if they decided they would like
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to receive it. Once the vaccination was given, then a follow up appointment for one month later
was made, as the vaccine needs to be given in two doses, one month apart. This was done so
that the patient knows to come back to the clinic to finish the vaccine series. In order to assess
compliance of the staff with implementing the intervention, pre-printed sheets with columns for
the staff to fill in were given (See Appendix B). The columns included date, patient initials,
screening done, eligible, not eligible, education given, accept or declined, given, and not given.
The staff added the date and patient initials and placed a checkmark in each of the boxes
regarding the immunization. These forms were then given to the project manager at the end of
each week.
While evidence supported the use of a paper reminder, the use of a reminder in the EHR
was also supported. This specific EHR system was unable to create a reminder for the initial
dose of the vaccination, but there was a reminder that was able to be created for the second
dose one month after the first dose. Validation needed to be completed as this was new to the
facility. This was completed over a period of three weeks by creating the reminder within the
EHR system and the staff assessing to make sure that the reminder popped up for each eligible
patient that received the vaccination. Once the MA or RN assessed if the patient would accept
the Men-B vaccination, they went into the EHR and click into a drop-down box named
“indication” and would choose “immunization”. This flagged the chart that the patient was given
the immunization. This flag was essential to this project as it allowed the project manager to run
a report for these specific students to assess compliance of staff with the intervention as well as
assess if the patient received the vaccination. This was placed under the chief complaint in the
EHR for ease of the staff to locate it. Once this was clicked, then the staff clicked a template to
the left of the chart called “Healthwatcher”. This template within the EHR showed student risk
factors and what vaccinations they may be due for based on manually placed criteria placed into
the set- up of the template. Once the staff clicked on “Healthwatcher”, they clicked “manage
plans”, chose the specific provider they were going to see, and then they clicked “assign
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Meningococcal B”. They then clicked a start date, which would be the date of the visit, clicked
“assign” and clicked “finish”. This then assigned the Men-B plan to this patient. Within this plan,
the staff could then schedule the students follow up appointment for their second dose of the
vaccination. Even if they did not set up an appointment that day, the EHR still populated a
reminder one month later which notified the student that they were due for the second dose of
the vaccination. If the student declined the vaccination, they still received an educational
brochure, but the staff then clicked “risk factor” on the left side of the chart, clicked “add new”,
and then clicked “Men-B susceptible”. They then clicked “current” under status as this was a
current risk factor for the patient, and then the staff placed a reason the patient declined the
vaccination in the comments section. They then clicked a checkmark to save the information.
This then notified staff that they have not received the Men-B vaccination and were at risk for
the disease. The staff had to click “risk factor” in the chart to assess the students risk factors.
The compliance form was kept to assess compliance of education given by the staff and to keep
track of patients that accepted or declined the vaccination. Throughout the implementation
process, it was noted that not all the patients that either received the vaccination or declined
and listed as a “risk factor”, were included in the many different reports that were ran. Therefore,
it was essential to keep the compliance form for the staff to be filled out. A form was printed with
a detailed list of the process for the staff, so they would have a reference (See Appendix A).
Comparison
Data from the SHC noted that from May 2018 to May 2019 there were 2,703 total health
center visits. There were no Men-B vaccinations given during this time as it was not available or
required at the time. The quadrivalent vaccine however, that targets Meningitis A, C, W, and Y,
was required beginning last year. There were 113 quadrivalent vaccinations given, but most
were international students or students that were new to the area from other states who did not
have the vaccination yet (K. Eshenaur, personal communication, 2019). Most high schools
were requiring this vaccination during that time, so many were not administered at the university
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(K. Eshenaur, personal communication, 2019). This EBP project aimed to provide awareness
regarding Men-B disease as well as the vaccination. This project also aimed to increase Men-B
vaccination rates among already established students.

Outcomes
The primary outcome of this EBP project was for students to be adequately screened for
risk of Men-B disease and for the eligible students to be vaccinated. Pre-printed sheets were
used to assess compliance of staff with the intervention of the paper reminder. Once the EHR
reminder was validated and implemented, a weekly report was conducted weekly by the project
manager to assess staff compliance with the intervention. The report included student charts
that were flagged “immunization” by the staff in the beginning of the visit as well as “risk factor” if
the patient declined the vaccination.
Time
The project ran over 13 weeks beginning September 3, 2019 and ended on December 4,
2019. This timeline provided enough time to obtain an adequate sample size of eligible
students. This period was a demanding time at the SHC as it is during cold and influenza
season, so opportunities for vaccinations were evident.

Protection of Human Subjects
Patient anonymity was maintained as the staff only placed patient initials and not full
names on the pre-printed compliance sheets. Once data was obtained by the project manager
from the pre-printed sheets, they were then shredded. Once the EHR reminder was
implemented, reports were run in the EHR to assess compliance of staff with intervention
modalities as well as assessment of Men-B vaccination rates. Patient anonymity was also
maintained as the EHR was password protected and reports were only conducted at the SHC in
a private location in the clinic. The demographic information as well as any student information
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never left the building and were not shared with anyone except the program director and
essential staff. A confidentiality statement was also signed at the beginning of this project for the
SHC.
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CHAPTER 4
FINDINGS

The purpose of this EBP project was to increase Men-B vaccination rates by using
identified best practices which included provider reminders, patient education, and a campuswide awareness campaign. The aim was to answer the following PICOT question: In college
students, does the implementation of an intervention to educate students on the meningitis
disease and importance of vaccination, a vaccination screening and provider reminder, and a
campus-wide vaccination campaign, as compared to no intervention, increase Men-B
vaccination rates, over thirteen weeks? After the implementation of this project, it was
determined that Men-B vaccination rates were, in fact, noted to be increased after the thirteenweek period.
Participants
Students that visited the SHC were the participants in this project and varied in age,
ethnicity, and grade level. The SHC began administering the Men-B vaccination on May 21,
2019. Prior to implementation of this EBP project, 258 students met eligibility requirements. Of
those 258, 56 received Men-B vaccinations. The demographics of these students included 24
freshmen (42.%), 9 sophomores (16%), 8 juniors (14.2%), 0 seniors (0%), and 15 graduate
(26.7%) students. The students were of various ethnic and racial backgrounds including 15
Caucasian (26.7%), 1 African American (1.7%), 3 Hispanic (5.3%), 11 Asian (19.6%), and Other
(46.4%). Gender was also included in the demographic analysis, 25 females (44.6%) and 31
males (55.3%).
This project began on September 3, 2019 and ended on December 4, 2019. During this
13-week period, there were a total of 896 students seen at the SHC, with ages ranging from 16
to 61 years of age. Of this student population, there were 267 students within the eligible age
range of 16-23 years old and 109 were deemed eligible (within age range, had not previously
received the vaccine, no freshman status) for the vaccination. Of these 109 eligible students, 70
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received the vaccination. These students were composed of sophomores (n=34, 48.6%),
Juniors (n= 18, 25.7%), Seniors (n= 9, 12.9%), and graduate students (n= 9, 12.9%). Racial
demographics included 52 Caucasian students(72.3%), 2 African American (2.9%), 3 Hispanic
(4.3%), 2 Asian (2.9%),1 American/Alaskan native (1.4%), 1 Chinese (1.4%), and 9 other or
unknown ethnicities (12.9%). Of those who received the vaccine, 41 were female (58.6%) and
29 were male (41.4%).
Of those students who received both the provider reminder and vaccination education,
27 did not opt to be vaccinated. These students were comprised of 12 sophomores (44.4%), 7
juniors (25.9%), 2 seniors (7.4%), and 6 graduate students (22.2%). These students were of
varying races; 10 Caucasian (37%), 1 African American (3.7%), 4 Hispanic (14.8%), 2 Asian
(7.4%), and 10 other or unknown ethnicities (37%). This group of students was comprised of 14
females (51.9%) and 13 males (48.1%).
During the implementation period, it was noted that some students did not receive the
vaccination education. These students consisted of 3 sophomores (25%), 3 juniors (25%), 1
senior (8.3%), and 5 graduate students (41.7%). These students were also of varying races; 5
Caucasian (41.7%), 1 African American (8.3%), 2 Asian (16.7%), and 4 other or unknown
(33.3%). There were 5 females (41.7%) and 7 males (58.3%). The demographics of the
students pre- and post-intervention are summarized in Table 4.1.
Changes in Outcomes
Statistical Testing and Significance
A chi-square test of independence was calculated to compare results of the preintervention group and the post-intervention group. It was determined that the intervention,
including provider reminder and vaccine education, had a statistically significant positive impact
on the uptake of the Men-B vaccine as compared to the pre-intervention period (X2 (1)=26.112,
p<0.05). For those participants who only received a provider reminder, there was also noted to
be a statistically positive impact on vaccination uptake as determined with a chi-square test of
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independence (X2 (1)= 26.828, p<0.05). However, education alone was found to have no
statistical impact on vaccination uptake (X2 (1)= 2.619, p>0.05).
Findings
Primary outcome.
The primary intended outcome of this EBP project implementation was to increase MenB vaccination rates at a midwestern university SHC through a multicomponent strategy. A
provider reminder was created and placed on each of the clinic’s five laptops to serve as a
reminder for clinicians and providers to offer and order the Men-B vaccination. Educational
brochures were provided to those eligible students regarding the Men-B disease, risk factors,
and vaccination information. A poster campaign was also implemented in buildings that students
frequented around campus, such as the student union, sorority houses, and the SHC lobby.
After a chi square analysis was completed, it was noted the project primary outcome was met
(X2 (1)= 26.112, p<0.05). There were more Men-B vaccinations given during implementation
than pre-intervention (n=70, n=56 respectively). With regards to the provider reminder alone,
there was a statistically significant finding (X2 (1)= 26.828, p<0.05), indicating that the provider
reminder had a positive effect on vaccination rates. When a chi square analysis was run on
education alone, there was not a significant statistical finding (X2 (1)= 2.619, p>0.05), indicating
that education alone may not influence Men-B vaccination rates.
Secondary outcomes
The clinic staff were trained to follow the EBP project protocol. Their compliance was
integral to successful implementation. Therefore, it was deemed important to monitor staff
compliance to the protocol implementation. Weekly audits were completed by the project
manager. During the beginning weeks of implementation, it was noted that staff were not
compliant with the protocol. The compliance form provided was not completed indicating that
there were twelve eligible students during the first three weeks that did not receive the
education. During week one, there were four eligible students that were missed who did not
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receive the education. During week two, five eligible students were missed, and week three,
three eligible students were missed. After a meeting with the staff for discussion on the
importance of compliance, staff were receptive and compliance rates went up to 100%. The
project manager was able to assist in screening once per week to help the staff during this busy
time.

14
12
10
8
6
4
2
0

Education Compliance

Vaccination uptake

While there were 70 students who received the vaccination, there were 27 that did not. An
inquiry was made by the clinician as to why students who opted to not receive the vaccination
did not. Some explanations given by the students include that they needed to speak to their
parents prior to receiving it, they did not want another vaccination if it was not required, they
were feeling ill at the time and wanted to wait, or simply wanted to think about it.
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Table 4.1
Demographics of the Students
Pre-Intervention
n (%)

Post-Intervention
n (%)

Total
N(%)

Gender
Female

25 (44.6)

41 (58.6)

66 (51.6)

Male

31 (55.4)

29 (41.4)

60 (48.4)

Caucasian

15 (26.8)

52 (72.3)

67 (49.5)

African American

1 (1.8)

2 (2.9)

3 (2.3)

Hispanic

3 (5.4)

3 (4.3)

6 (4.8)

Asian

11 (19.6)

2 (2.9)

13 (11.2)

Race

Amer/Alask Native 0

(0)

1 (1.4)

1 (1.4)

Chinese

0

(0)

1 (1.4)

1 (1.4)

Other

26

(46.4)

9 (12.9)

35 (29.6)

Grade
Freshman

24 (42.9)

0 (0)

24 (42.9)

Sophomore

9 (16.1)

34 (47.2)

43 (31.6)

Junior

8

(14.3)

18 (25)

26 (19.6)

Senior

0

(0)

Graduate

15 (26.8)

9 (12.5)

9 (12.5)

9 (12.5)

24 (19.6)
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CHAPTER 5
DISCUSSION

The purpose of this EBP project was to determine if a multicomponent strategy would
increase Men-B vaccination rates at a midwestern university SHC. There was no intervention in
place prior to implementation. The intervention consisted of a provider reminder placed on each
of the five staff laptops in the SHC, educational brochures regarding Men-B disease and
vaccination were given to the eligible students who visited the SHC during the 13-week
intervention period as well as a poster campaign around campus. The explanation of findings
the strengths and limitations of this EBP project, and the evaluation of the EBP model utilized
with this EBP project implementation will be discussed in this chapter.
Explanation of Findings
The purpose of this EBP implementation was to determine if a multicomponent
intervention, including a clinician reminder, patient education, and a campus-wide campaign
would increase Men-B vaccination rates at a small, midwestern university SHC. The project was
implemented over 13 weeks in the Fall of 2019. It was determined that the implementation did
increase Men-B vaccination uptake in the population of focus. The EBP was successful in
increasing Men-B vaccination rates.
Pre-intervention, there were 258 students who visited the SHC who were eligible for the
Men-B vaccine. Of those, 56 (22%) received the vaccination compared to 70 students out of
109 eligible students (64%) receiving the vaccination post-intervention. (X2 (1)=26.112, p<0.05).
A 40% increase in the Men-B vaccination rates at the SHC was noted. Similar results were
noted in a study by Humiston et al (2011) in which provider reminders were utilized in order to
increase vaccination uptake. The control group was noted to have a 22% vaccination rate and
the intervention group was noted to have a 62% vaccination rate. A chi-square analysis was
conducted on the provider reminder (X2(1)=26.828, p<0.05) indicating a statistical significance.
These findings indicate that a provider reminder alone could assist in increasing vaccination
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uptake. Similarly, a study performed by Arditi (2017) noted an 11% increase in vaccination rates
with a provider reminder alone. Zimet et al (2017) also noted in their study of an elaborated
prompt to the provider to screen and offer recommended vaccinations, resulted in a 62%
vaccination rate compared to a 45% vaccination rate prior to the intervention. The findings
demonstrated from this EBP project were consistent with the findings identified from the
literature review. A chi-square analysis was conducted on those participants who only received
the education as an intervention (X2(1)=2.619, p>0.05), which was not statistically significant,
indicating that education alone may not be enough to increase vaccination uptake. This result
could have occurred because there was not a process included in project implementation to
assess if education had an impact on the students reasoning for accepting or declining the
vaccination such as a post-visit survey or questionnaire.
Strengths and Limitations of the DNP Project
Strengths
Perhaps the greatest strength of this EBP implementation is the impact on vaccination
uptake amongst this high-risk patient population. Meningococcal disease can be fatal if
contracted, so vaccination is essential. Education of clinic staff and their involvement in this EBP
project was another strength. The staff were able to learn more about the disease and the
importance of vaccination during this process. Additionally, the ability to utilize an EHR during
the implementation was a strength. Francis et al (2017) note that utilizing EHR’s as well as
interventions that specifically target providers should be a priority to help improve vaccination
rates. The EHR was an essential part of the implementation process in this EBP project. It
allowed for reports to be developed regarding vaccinations received and declined during the 13week time period. This also allowed the project manager to assess compliance with the
vaccination protocol. Lastly, the staff at the SHC were essential to this project as they were on
the front lines of implementation. Their duty was to screen patients for eligibility, provide
education, offer and administer the vaccination if the student accepted it. They were also
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responsible for entering the acceptance or declination of the vaccine into the EHR, which
assisted with data collection.
Limitations
At the onset of this EBP project development, it was noted that the university was
mandating the Men-B vaccine for all freshman students beginning August 2019. Due to this
mandate, freshman students were excluded as participants. However, during implementation it
was noted that many freshman students who visited the SHC had not received the Men-B
vaccine. This was a limitation in terms of demonstrating the true significance of this project, as it
was noted the interventions also resulted in vaccination uptake. Staff compliance was also
considered a limitation for this project, especially in the first few weeks of implementation. The
staff were to fill out a form to measure their compliance with the intervention. During the early
stages of implementation, the staff admitted that they were not compliant with filling out the form
or with performing the intervention. Due to this, there may have been missed opportunities to
offer and educate about the vaccination. Another limitation of the project was that there was not
a way to assess if the education had any impact on the students. Throughout the literature
review that was conducted prior to implementation, best practice did not indicate a means of
conducting surveys or questionnaires as part of the evaluation process. This would have been
beneficial to this project to see if education may have led to future students’ decision to
vaccinate. While a campus-wide poster campaign was also implemented, there was no
developed mechanism to capture the impact of this piece of the EBP project implementation.
Implications for the Future
The primary objective of this EBP project was to increase Men-B vaccination rates
based on evidence depicted in the extensive literature review. The objective was met through
the implementation of a provider reminder, educational brochures, and a poster campaign at a
midwestern university college campus SHC. The findings included a statistically significant
increase in Men-B vaccination rates when compared to the three months prior to
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implementation. Since the data indicated an increase in vaccination rates, implications for the
future are discussed.
Practice. An increase in Men-B vaccination rates post implementation of this EBP project
suggests that continuation of the intervention of a provider reminder is essential. Even though
there was not a statistically significant increase in vaccination rates due to the education, this
was considered an essential part of the implementation. Students need to know the signs and
symptoms of disease as well as the risks and benefits of the vaccination. A post-visit survey or
questionnaire would be helpful for future EBP projects to assess if the education given had an
impact on whether the student accepted the vaccination. Since statistical significance was
associated with the provider reminder aspect of the project, efforts should be continued to
increase Men-B vaccination uptake in practice. College students 23 years of age or under
continue to be at risk for the Men-B disease and continuous attempts for vaccination should be
implemented. The APRN is an essential component to such a strategy in the role of education
and utilizing their platform as a means of campaign. Future projects could utilize various forms
of campaign by the APRN including social media, email, and even telehealth to advise the atrisk population of the importance of vaccination.
Theory. The Stetler Model served as the driving force for this EBP project. The model is
divided into five different phases: (1) preparation, (2) validation, (3) comparative
evaluation/decision making, (4) translation/application, and (5) evaluation (Melnyk & FineoutOverholt, 2015). Prior to implementation, the preparation phase was followed according to the
model. This included identifying a need for an increase in Men-B vaccination rates with key
stakeholders. This also included performing a literature search to find the best evidence related
to vaccination uptake. During the validation phase, evidence was reviewed and critiqued using
the JHNEBP appraisal tool. The third phase of the model included comparing evidence and
identifying similarities between them. The evidence showed that a provider reminder paired with
educational modalities and a poster campaign was best practice to increase vaccination uptake.
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Translation and application of the evidence was relayed during the fourth phase by educating
the staff of the SHC of the workflow with educational brochures, a provider reminder placed on
each of the five clinic laptops, and placing posters around campus regarding the disease and
vaccine. During the final phase of the model, data were evaluated for statistical findings. This
model was essential to this project as it provided a step by step guide that was easily followed
throughout the process. The model would be beneficial to practitioners in the future who can
utilize a step by step process.
Research. Throughout the preparation phase of the project, an intensive literature search was
conducted to find the most up to date evidence for increasing vaccination uptake. The search
concluded that best practice should include a multicomponent approach. This approach
included a provider reminder to offer and order the vaccination, educational efforts, and a poster
campaign around campus. The search was aimed at vaccination uptake among college
students since this was the specific population for this EBP project. Future research is
implicated to address the best mode of education to use with college students. Even though the
educational effort was not noted to be statistically significant related to this project, education is
still needed, and nursing research should be focused on what college students would be most
receptive to. Reasons for not receiving the vaccination among the population at the SHC
included that they did not want another shot if it was not required, they needed to speak with
their parents, they were feeling ill at the time, or they simply did not want to receive the
vaccination. Mandating the vaccination amongst this high-risk population should be included at
every university. Students need to understand fully the risks involved of not receiving the
vaccine. Further campaigns should focus on the mortality rate of Men-B as well as the
consequences of contracting the disease such as neurological impairment. Further
implementation should be acquired through additional provider reminders. Ruffin et al (2015)
and Shojania (2009) indicate that point of care reminders utilized in the EHR are useful when
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trying to increase vaccination uptake. Further research should be conducted to fully understand
the content of these reminders and when they will display on the chart.
Education. Further implications are needed with regards to APRN education and the Men-B
disease and vaccination. The APRN role serves as an essential part of this process to educate
college students who are at increased risk for Men-B disease and to encourage the process of
vaccination. In order to provide education, they need to be educated as well. This could be done
through seminars, conferences, and continuing education focused on vaccination uptake in
general. Educational efforts for the future for the APRN to utilize may include further brochures,
posters, emails, use of social media, text messages, and even letters through the mail.
Education needs to be implicated when healthcare is involved. The APRN and patients,
especially students need to be taught the importance of vaccination and disease prevention.
Conclusion
The provider reminder incorporated into this project resulted in a statistically significant
result indicating a positive outcome on Men-B vaccination rates. Despite the educational efforts,
this aspect of the project did not result in statistical significance. However, attempts to educate
students regarding the Men-B disease and vaccination are essential to promoting healthy
practices and vaccination uptake. The primary outcome of this EBP project was met overall by
increasing Men-B vaccination rates. The disease can be fatal if contracted and the best defense
is vaccination in this vulnerable group of college students. The APN role is essential to this
practice of education and offering the vaccination to eligible students. The APN serves many
roles, especially the educator and the facilitator for the vaccination. The SHC should continue with
the provider reminder as well as educational efforts. Ruffin et al (2015) notes that providers who
receive a prompt to offer a vaccination and follow through are more likely to have patients receive
the recommended vaccination and complete the whole series of the vaccination if needed. A
multicomponent strategy is essential for increased vaccination uptake. APN’s are the champions
in health promotion and strategy. They are on the front lines and need to advocate to their
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patients, especially the most vulnerable populations, the importance of vaccination and disease
prevention.

MENINGOCOCCAL PROTOCOL

64
REFERENCES

Arditi, C., Rege-Walther, M., Durieux, P., & Burnand, B. (2017). Computer-generated reminders
delivered on paper to healthcare professionals: Effects on professional practice and
healthcare outcomes (review). Cochrane Database of Systematic Reviews, 7(7), 1-107.
doi:10.1002/14651858.CD001175.pub4
Baker, C. J., M.D. (2016). Prevention of meningococcal infection in the united states: Current
recommendations and future considerations. Journal of Adolescent Health, 59(2), S29S37. doi:10.1016/j.jadohealth.2016.03.040
Balada-Llasat, J. M., Rosenthal, N., Hasbun, R., Zimmer, L., Ginocchio, C. C., Duff, S., . . .
Bozzette, S. (2018). Cost of managing meningitis and encephalitis among adult patients
in the united states of america. International Journal of Infectious Diseases, 71(C), 117121. doi:10.1016/j.ijid.2018.04.799
Crum-Cianflone, N., & Sullivan, E. (2016). Meningococcal vaccinations. Infectious Diseases and
Therapy, 5(2), 89-112. doi:http://dx.doi.org.ezproxy.valpo.edu/10.1007/s40121-0160107-0
Francis, D. B., Cates, J. R., Wagner, K. P. G., Zola, T., Fitter, J. E., & Coyne-Beasley, T. (2017).
Communication technologies to improve HPV vaccination initiation and completion: A
systematic

review.

Patient

Education

and

Counseling,

100(7),

1280-1286.

doi:10.1016/j.pec.2017.02.004
Daly, K. L., Halon, P. A., Aronowitz, T., & Ross, G. (2016). A university health initiative to
increase human papillomavirus vaccination rates. The Journal for Nurse Practitioners,
12(6), e281-e286. doi:10.1016/j.nurpra.2016.02.013
Dang, D., & Dearholt, S. L. (2017). Johns hopkins nursing evidence-based practice: Model and
guidelines.(3rd ed.). Retrieved from https://ebookcentral-proquest-com.ezproxy.valpo.edu

MENINGOCOCCAL PROTOCOL

65

D’Agostino, S. (2016). Utilization of EHR provider prompts to maximize adult pertussis
immunization rates. Journal of Doctoral Nursing Practice, 9(2), 183-188.
doi:10.1891/2380-9418.9.2.183
Enhanced Meningococcal Disease Surveillance Report, 2017. (2017). In Center for Disease
Control. Retrieved from https://www.cdc.gov/meningococcal/downloads/NCIRD-EMSReport-2017.pdf
Health Advisory: Meningococcal Disease. (2019). In Columbia University. Retrieved from
https://health.columbia.edu/news/health-advisory-meningococcal-disease
Health Advisory – Serogroup B Meningococcal Disease. (2019). In Rutgers University.
Retrieved from http://health.rutgers.edu/meningitis/#MeningitisB-Key-Points
Humiston, S. G., Bennett, N. M., Long, C., Eberly, S., Arvelo, L., Stankaitis, J., & Szilagyi, P. G.
(2011). Increasing inner-city adult influenza vaccination rates: A randomized controlled
trial. Public Health Reports (1974-), 126(2_suppl), 39-47.
doi:10.1177/00333549111260S206
Jaca, A., Mathebula, L., Iweze, A., Pienaar, E., & Wiysonge, C. S. (2018). A systematic review
of strategies for reducing missed opportunities for vaccination. Vaccine, 36(21), 29212927. doi:10.1016/j.vaccine.2018.04.028
Koch, J. A. (2012). Strategies to overcome barriers to pneumococcal vaccination in older adults:
An integrative review. Journal of Gerontological Nursing, 38(2), 31-39.
doi:10.3928/00989134-20110831-03
Meningococcal Disease. (2019). In Health and Human Services Agency. Retrieved from
https://www.sandiegocounty.gov/content/sdc/hhsa/programs/phs/community_epidemiolo
gy/dc/Meningococcal.html

Meningococcal Meningitis. (2019). In World Health Organization. Retrieved from
https://www.who.int/immunization/diseases/meningitis/en/

MENINGOCOCCAL PROTOCOL

66

Meningococcal Outbreaks. (2019). In Center for Disease Control. Retrieved from
https://www.cdc.gov/meningococcal/outbreaks/index.html
Melnyk, B. M., & Fineout-Overholt, E. (2015). Evidence-based practice in nursing and
healthcare (3rd ed.). Philadelphia: LWW.
Mohammed, H., McMillan, M., Roberts, C., & Marshall, H. (2019). A systematic review of
interventions to improve uptake of pertussis vaccination in pregnancy. Plos One, 14(3), 114 doi:10.1371/journal.pone.0214538
Peterson, M. E., Mile, R., Li, Y., Nair, H., & Kyaw, M. H. (2018). Meningococcal carriage in highrisk settings: A systematic review. International Journal of Infectious Diseases, 73, 109117. doi:10.1016/j.ijid.2018.05.022
Ruffin, M., Plegue, M., Rockwell, P., Young, A., Patel, D., & Yeazel, M. (2015). Impact of an
electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation
and timely completion. Journal of the American Board of Family Medicine, 28(3), 324-333.
doi:10.3122/jabfm.2015.03.140082

Schmidt, N. A., & Brown, J. M. (2019). Evidence-based practice for nurses: Appraisal and
application of research (4th ed.). Burlington:Jones and Bartlett.

Shojania, K., Jennings, A., Mayhew, A., Ramsay, C., Eccles, M., & Grimshaw, J. (2009). The
effects of on-screen, point of care computer reminders on processes and outcomes of
care. (review). Cochrane Database of Systematic Reviews, (3), CD001096-CD001096.
doi:10.1002/14651858.CD001096.pub2

Stetler, C. (2001). Updating the Stetler model of research utilization to facilitate evidence-based
practice. Nursing Outlook, 49, 272-279. doi: 10.1067/mno.2001.120517

MENINGOCOCCAL PROTOCOL

67

Stetler, C. (2010). Chapter 3: Stetler Model. In J. Rycroft-Malone & T. Bucknall (Eds.) Evidencebased Practice Series. Models and frameworks for implementing evidence-based
practice: Linking evidence to action. Oxford: Wiley-Blackwell.

Tan, L. (. J. ). (2018). A review of the key factors to improve adult immunization coverage rates:
What can the clinician do? Vaccine, 36(36), 5373-5378.
doi:10.1016/j.vaccine.2017.07.050

Valparaiso University. (2019). 2019-2020 Student injury and sickness insurance plan Retrieved
from https://www.valpo.edu/student-health-center/files/2019/07/2019-1457-1-SummaryBrochure.pdf

Zimet, G., Dixon, B. E., Xiao, S., Tu, W., Kulkarni, A., Dugan, T., . . . Downs, S. M. (2018).
Simple and elaborated clinician reminder prompts for human papillomavirus vaccination:
a randomized clinical trial. Academic Pediatrics, 18(2), S66-S71.
doi:10.1016/j.acap.2017.11.002

MENINGOCOCCAL PROTOCOL

68

BIOGRAPHICAL MATERIAL
Valerie M. Cline

Mrs. Cline graduated with an Associate of Science degree in Nursing from Ivy Tech Community
College in 2009. She received her Bachelor of Science in Nursing from Valparaiso University in
2013. She has been employed at St. Catherine Hospital in East Chicago, IN since 2008. She
began as an RN fellow and then became a registered nurse in 2009, with a focus on
medical/surgical and orthopedic nursing. During that time, she also received training on the
intermediate care unit (IMCU). Valerie is currently attending Valparaiso University to obtain the
Doctor of Nursing Practice (DNP) degree with an anticipated graduation date of May 2020. She
also became a member of Sigma Theta Tau International-Zeta Epsilon chapter in 2018. Her
evidence-based practice project focused on a multicomponent approach to increasing
meningococcal B vaccinations among college students. She is a firm believer in preventative
medicine, and she hopes to focus on women’s health upon graduation and board certification.

MENINGOCOCCAL PROTOCOL

69
ACRONYM LIST

ACE: Academic Center for Evidence-Based Practice
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Appendix A

Meningitis B Vaccination Process
MA & RN:
Screening: 23 years of age and under
Has not received Men-B previously
If meets criteria: notify them that they meet criteria for Men-B vaccination and offer vaccine
If they are accepting the vaccine or thinking about it, place RED educational brochure outside
of door to remind the provider to offer vaccination and educate, if they decline, give them
PURPLE brochure
Providers: please educate in the exam room , order vaccine if applicable
MA & RN:
If patient accepts:
•
•

Click on Indication (under chief complaint), choose Immunization
Click Health Watcher
▪ Manage plans
▪ Choose provider
▪ Click assign Meningococcal B
▪ Click include start date and frequency
▪ Click assign
▪ Click finish

If patient declines:
•
•
•
•
•

Click on risk factor in left menu
Click add new (+)
Click Men-B susceptible
Click status: Current
In comment, put reason for not receiving, then click checkmark to save

*When you open the chart, if Health-watcher reminder pops up that patient is overdue, that
means that the patient received the Men-B vaccine already. It will show the date that it was
given. It will also pop up when the patient is due for their second dose.
*If patient receives the vaccine, try to get them to schedule their 1- month appointment for 2nd
dose
*Please fill out Men-B compliance form even if they declined it, or have already received it, but
meet criteria (if they have already had it, write that on the sheet, if they are freshmen, place an F
at the end of the row)
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Appendix B

Date

Pt initials

Screening
completed

Eligible

Noneligible

Education
given

Accepted

Declined

Staff
initials
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